{"gene":"TOP1","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":1988,"finding":"Human TOP1 was cloned from a cDNA library; the catalytically active domain resides in the C-terminal 67.7-kDa fragment (carboxyl terminus, including active-site Tyr-723), which relaxes supercoiled DNA in vitro and shares 42% identity with yeast Top1.","method":"cDNA cloning from λgt11 expression library, in vitro DNA relaxation assay, proteolysis mapping, immunoprecipitation with anti-topoisomerase I serum","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — reconstitution of enzymatic activity + sequence validation + immunoprecipitation in a single foundational study","pmids":["2833744"],"is_preprint":false},{"year":1985,"finding":"Yeast TOP1 (encoding DNA topoisomerase I) was cloned and shown to be a single-copy gene whose deletion is viable in haploid cells; however, combined deletion of TOP1 and the temperature-sensitive TOP2 is lethal even when mitotic arrest prevents TOP2-mediated death, demonstrating that TOP1 serves an auxiliary but distinct role in chromosome metabolism complementary to TOP2.","method":"Immunological screening of genomic library, construction of insertion/deletion mutants, cell viability assays, temperature-shift experiments with synchronised top1Δ top2-ts double mutants","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — direct genetic knockout with defined cellular phenotype, replicated across conditions","pmids":["2997777"],"is_preprint":false},{"year":1998,"finding":"Crystal structures of human topoisomerase I (core + C-terminal domains) in covalent and noncovalent complexes with 22-bp DNA at 2.1 Å and 2.5 Å resolution reveal that the enzyme clamps around essentially B-form DNA; the active-site nucleophile Tyr-723 is in the C-terminal domain; the core domain shares structural similarity with phage integrases; a binding site for camptothecin at the enzyme-DNA interface was proposed.","method":"X-ray crystallography at 2.1 Å (noncovalent) and 2.5 Å (covalent) resolution","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structures of enzyme-DNA complexes, foundational study cited >600 times","pmids":["9488644"],"is_preprint":false},{"year":1998,"finding":"Crystal structure of human TOP1 bound to a 22-bp DNA duplex (2.8 Å) revealed a coiled-coil linker domain protruding away from the enzyme-DNA interface; key catalytic residues were identified; the structure led to the 'controlled rotation' model for DNA relaxation, in which the downstream DNA rotates around the intact strand after Top1-mediated single-strand nicking.","method":"X-ray crystallography at 2.8 Å resolution of amino-terminally truncated TOP1–DNA complex","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mechanistic model validated against biochemical data, foundational study","pmids":["9488652"],"is_preprint":false},{"year":2002,"finding":"X-ray crystal structure of human topoisomerase I covalently joined to DNA and bound to the anticancer drug Topotecan (camptothecin analog) showed that Topotecan intercalates between the −1 and +1 base pairs at the cleavage site, displacing the downstream DNA and preventing religation, thereby acting as an uncompetitive inhibitor of the enzyme-substrate complex; direct drug contacts with TOP1 residues R364, D533, and N722 were identified.","method":"X-ray crystallography of ternary TOP1–DNA–Topotecan cleavage complex","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure of ternary complex directly explains camptothecin mechanism of action","pmids":["12426403"],"is_preprint":false},{"year":2002,"finding":"In yeast, the tyrosyl-DNA phosphodiesterase Tdp1 and the structure-specific endonuclease Rad1-Rad10 function as two primary and redundant pathways for repairing TOP1 replicative damage (Top1 cleavage complexes at replication forks); both pathways require RAD52, RAD51, and RAD50 for subsequent recombination-dependent repair; double tdp1 rad1 mutants show TOP1-dependent growth delay and extreme camptothecin sensitivity.","method":"Yeast genetic epistasis analysis, camptothecin sensitivity assays, double-mutant construction including catalytic point mutants","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — extensive genetic epistasis with multiple alleles and double mutants, replicated across pathways","pmids":["12368472"],"is_preprint":false},{"year":2007,"finding":"In S. cerevisiae, Top1 and Top2 act within a ~600 bp region spanning moving replication forks to relieve torsional stress; TOP1 ablation alone does not impair fork progression or activate the Rad53 checkpoint kinase, but top1 top2 double mutants exhibit fork block, processing, and phosphorylation of Rad53 and γH2A in S-phase, demonstrating a coordinated/redundant role of both topoisomerases at replication forks.","method":"Chromatin immunoprecipitation (ChIP) genome-wide mapping of Top1 and Top2 on replicating chromosomes, genetic analysis of top1, top2 and top1 top2 mutants, checkpoint kinase assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP combined with genetic epistasis and defined molecular phenotypes","pmids":["17671091"],"is_preprint":false},{"year":2008,"finding":"Deletion of TOP1 in yeast specifically increases transcription of telomere-proximal genes and alters histone modification: loss of Top1 or expression of an inactive Y727F Top1 mutant increases H4 histone acetylation at the rDNA locus and at telomere-proximal regions; immunoprecipitation showed Top1 binds telomeric DNA repeats and is catalytically active there, indicating that Top1 catalytic activity promotes a repressed chromatin state at subtelomeric regions.","method":"Gene expression microarrays, chromatin immunoprecipitation (ChIP), yeast deletion and catalytic-point mutant analysis","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP + transcriptomics + catalytic mutant, single lab","pmids":["18272174"],"is_preprint":false},{"year":2011,"finding":"The SUMO-targeted ubiquitin ligase (STUbL) Rad60 and the SUMO E3 ligase Nse2 suppress spontaneous Top1 cleavage complex (Top1cc) formation in fission yeast; cells with reduced STUbL activity are dependent on Tdp1 for viability, and detection of Top1ccs by ChIP-qPCR confirmed elevated Top1ccs in cells lacking Tdp1 combined with STUbL, Rad60 or Nse2 deficiency; epistasis analyses placed STUbL/Rad60/Nse2 in the Rad16-Swi10 (NER endonuclease) pathway for Top1cc repair.","method":"Genetic epistasis, ChIP-qPCR detection of Top1cc, camptothecin sensitivity assays, fission yeast genetics","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-qPCR quantification of Top1cc + epistasis, single lab","pmids":["21408210"],"is_preprint":false},{"year":2014,"finding":"Reversible Top1 cleavage complexes (Top1ccs) are specifically stabilized strand-specifically at the ribosomal DNA replication fork barrier (rRFB) of budding yeast in a manner requiring Fob1 and Tof2 proteins; this stabilization is replication-independent, reversible (not subject to Tdp1 or Mus81 repair), and correlates with Top1-provided rDNA stability, establishing a novel physiologically regulated mode of Top1 action at the rRFB.","method":"ChIP at engineered and native rRFB loci, genetic analysis of fob1, tof2, tdp1, mus81 mutants, strand-specific detection of Top1cc","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP with genetic validation and strand-specific assay, single lab","pmids":["24574527"],"is_preprint":false},{"year":2016,"finding":"PARylation of Top1 by PARP1 regulates Top1 subnuclear dynamics: PARP inhibitors (Veliparib/ABT-888) delocalize Top1 from the nucleolus to the nucleoplasm independently of Top1-PARP1 direct interaction; PARP inhibition markedly increases the CPT-induced immobile (Top1cc) fraction of Top1 across the nuclear genome; Top1 residues Trp205 and Asn722 are critical for subnuclear dynamics; the N722S mutant is restricted to the nucleolus in CPT and is deficient in CPT-induced PARylation and Top1cc formation.","method":"Live-cell imaging with GFP-tagged Top1, fluorescence recovery after photobleaching (FRAP) with kinetic modelling, PARP inhibitor treatment, site-directed mutagenesis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 — live-cell FRAP + mutagenesis + kinetic modelling, multiple orthogonal methods in single study","pmids":["27466387"],"is_preprint":false},{"year":2016,"finding":"Top1 performs ribonucleotide-dependent deletions via a sequential double-cleavage mechanism: Top1 incises at a ribonucleotide, forming a Top1cc, and a second Top1 cleavage event creates a gap; complementarity within a tandem repeat then promotes realignment and Top1-mediated ligation to generate a deletion; parallel in vitro and in vivo analyses confirmed that deletion size is determined by the distance between two Top1 cleavage sites, and downstream complementarity promotes deletion more effectively than upstream complementarity.","method":"Parallel in vitro Top1 cleavage assays with defined substrates and in vivo yeast mutation assays; deletion mapping","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro mechanism confirmed in parallel in vivo, mechanistic model directly tested","pmids":["27257064"],"is_preprint":false},{"year":2019,"finding":"Apn2 (AP endonuclease 2) in S. cerevisiae resolves Top1-mediated 3′ end blocks including phosphotyrosine-DNA conjugates (Top1cc), 2′,3′-cyclic phosphates, and their hydrolysis products; APN2 deletion suppresses 2-bp slippage mutagenesis in RNH201-deficient cells, placing Apn2 as an additional nuclease that processes Top1-induced DNA ends independently of Tdp1.","method":"Yeast genetics (deletion mutants, epistasis), in vitro biochemical assays with defined DNA substrates bearing 3′ adducts","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro enzymatic activity on defined substrates combined with genetic epistasis","pmids":["30778235"],"is_preprint":false},{"year":2019,"finding":"Large Top1cc-dependent deletions in yeast are produced by the nonhomologous end-joining (NHEJ) pathway and require removal of Top1 from DNA ends; these deletions accumulate in quiescent cells, suggesting that Top1-associated DSBs can arise outside of replication, with NHEJ joining ends from different Top1-associated DSBs to delete intervening sequence.","method":"Yeast genetics with NHEJ mutants, Top1cc stabilisation by top1-T722A allele and CPT, molecular characterisation of deletion junctions","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with junction-level molecular characterisation, single lab","pmids":["31636207"],"is_preprint":false},{"year":2020,"finding":"In budding yeast, Top1 physically interacts with the fork protection complex component Tof1 through Tof1's C-terminal domain; this interaction is required for programmed replication fork pausing at the rDNA replication fork barrier (RFB), and Top2 can partially compensate for the absence of Top1 in this context.","method":"Physical interaction assays (Tof1-Top1 interaction), genetic analysis of tof1 mutants defective for Top1 binding, replication fork pausing assays at rDNA RFB","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2–3 — protein interaction + genetic analysis, commentary citing primary work by Shyian et al.","pmids":["31896687"],"is_preprint":false},{"year":2021,"finding":"TDP1-independent repair of Top1cc in yeast involves the nucleotide excision repair pathway components Rad16-Swi10 as alternative Top1cc repair factors; Top1cc-induced DNA damage causes hyper-recombination and checkpoint-mediated cell cycle arrest when both Tdp1 and this NER pathway are absent.","method":"Yeast epistasis genetics, ChIP-qPCR quantification of Top1ccs, checkpoint analysis","journal":"NAR cancer","confidence":"Medium","confidence_rationale":"Tier 2 — review synthesising ChIP and genetic data from primary studies; mechanistic synthesis","pmids":["33981998"],"is_preprint":false},{"year":2021,"finding":"Abraxas restricts SLX4/MUS81 recruitment to CPT-induced (TOP1cc-derived) single-ended DSBs by counteracting K63-linked ubiquitin modification; without Abraxas, uncontrolled SLX4/MUS81 loading leads to excessive MRE11-CtIP-DNA2/BLM-dependent end resection and increased break-induced replication (BIR) via RAD52- and POLD3-dependent, RAD51-independent synthesis, resulting in chromosome aberrations.","method":"Genetic knockouts (Abraxas, SLX4, MUS81, MRE11, CtIP, RAD52, POLD3, RAD51), camptothecin treatment, measurement of mitotic DNA synthesis, ubiquitin modification assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — multiple isogenic knockouts with mechanistic pathway dissection and functional readouts","pmids":["34272385"],"is_preprint":false},{"year":2022,"finding":"Crystal structure of the archaeal Caldiarchaeum subterraneum CsTOP1 in apo (DNA-free) open conformation revealed that the enzyme consists of capping (CAP) and catalytic (CAT) modules connected by a flexible five-residue hinge loop; a conserved tyrosine near the hinge mediates the transition from open to closed conformation upon DNA binding; directed mutagenesis of hinge residues confirmed the importance of hinge flexibility and linked enzyme dynamics to camptothecin sensitivity.","method":"X-ray crystallography of apo-form archaeal TOP1, directed mutagenesis of hinge residues, camptothecin sensitivity assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — crystal structure + mutagenesis + functional validation in one study","pmids":["35013228"],"is_preprint":false},{"year":2022,"finding":"Whole-genome CRISPR screens in TDP1-knockout cells identified MUS81 as a key mediator of excess DSB formation when TDP1 is absent: TDP1 KO cells show synthetic lethality with APEX1/2 deficiency but not via reduced DSB formation, indicating that TOP1cc can be either directly resolved by TDP1 or converted to DSBs and repaired by the homologous recombination pathway.","method":"Unbiased whole-genome CRISPR screens, generation of TDP1/MUS81 and TDP1/APEX co-deficient cell lines, DSB quantification","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — unbiased CRISPR screen validated in isogenic co-deficient cells with mechanistic DSB readouts","pmids":["35869071"],"is_preprint":false},{"year":2022,"finding":"TOP1-mediated mutagenesis at genome-embedded ribonucleotides generates a characteristic insertion-deletion mutational signature (ID4: 2–5 bp deletions at TNT motifs); defective ribonucleotide excision repair in mammals leads to accumulation of this TOP1-mediated signature both in cancer and in the germline, establishing that TOP1 activity at rNMP sites is a source of somatic and germline mutations.","method":"Mutational signature analysis in cancer genomes and germline de novo mutations, mouse models with defective ribonucleotide excision repair, identification of TNT sequence motif","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — mechanistic link between TOP1 and rNMP-dependent mutagenesis established in mammalian models and human cancer/germline data","pmids":["35140396"],"is_preprint":false},{"year":2022,"finding":"Exatecan forms two novel molecular contacts with the TOP1 cleavage complex beyond the three classical camptothecin interaction sites (R364, D533, N722): additional interactions with the flanking DNA base and TOP1 residue N352 result in stronger TOP1 trapping and higher DNA damage than classical camptothecin derivatives.","method":"Molecular modelling of exatecan in the TOP1 cleavage complex, comparison of TOP1 trapping and DNA damage with clinical TOP1 inhibitors, cell-based apoptosis and xenograft assays","journal":"Molecular cancer therapeutics","confidence":"Medium","confidence_rationale":"Tier 1/3 — structural modelling supported by cellular and in vivo pharmacological data, but no direct crystal structure of exatecan-TOP1cc","pmids":["35439320"],"is_preprint":false},{"year":2022,"finding":"TOP1 CAD-seq protocol enables genome-wide mapping of TOP1 sites of covalent engagement (cleavage complexes) with DNA using chaotropic salt enrichment and immunoprecipitation with a TOP1-specific antibody, without crosslinking, providing low-background maps of catalytically active TOP1 across the human genome.","method":"Chaotropic salt-based enrichment of TOP1-DNA adducts, anti-TOP1 immunoprecipitation, Illumina sequencing","journal":"STAR protocols","confidence":"Medium","confidence_rationale":"Tier 2 — methodological paper describing direct biochemical capture of TOP1cc genome-wide","pmids":["35942340"],"is_preprint":false},{"year":2023,"finding":"Abortive TOP1 activity during gene transcription generates protein-linked SSBs (TOP1cc) that can lead to DSBs; these transcription-associated DSBs are a source of chromosomal translocations suppressed by TDP1; the translocations arise via an error-prone pathway requiring the MRN complex and canonical NHEJ, distinct from replication-associated TOP1 damage.","method":"Human cell TDP1 depletion, chromosomal translocation mapping, DSB mapping during transcription, MRN and NHEJ pathway genetic dissection","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — genetic dissection of pathway with chromosomal-level mechanistic readouts, multiple independent validations","pmids":["37945566"],"is_preprint":false},{"year":2023,"finding":"MUS81 can cleave DNA-protein cross-links (DPCs) derived from TOP1, but only after TOP1 has been dislodged or partially proteolytically degraded (native full-length TOP1 blocks MUS81 cleavage); depletion of TDP1 in MUS81-KO cells confers sensitivity to CPT and affects cell proliferation only partially rescued by TOP1 depletion, indicating that MUS81 and TDP1 act in independent pathways to remove TOP1-derived lesions.","method":"In vitro MUS81 cleavage assays on DPC substrates (fluorescein, streptavidin, proteolytically processed TOP1), nuclear extract cleavage assays, TDP1/MUS81 double-KO cell viability assays, CPT sensitivity","journal":"BMC biology","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro reconstitution with defined substrates plus genetic knockouts with functional readouts","pmids":["37194054"],"is_preprint":false},{"year":2024,"finding":"TOP1 and R-loops co-occupy highly transcribed cancer driver genes; depletion of R-loops (by RNase H overexpression) or depletion of TOP1 significantly reduces transcription-associated DSBs at these loci, demonstrating that TOP1 and R-loops cooperate to generate DSBs at hypertranscribed genes, contributing to early driver mutations in cancer.","method":"DSB mapping, R-loop mapping (DRIP-seq), TOP1cc mapping, TOP1 and RNase H depletion experiments in cancer cells","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 — multiple genomic mapping methods combined with TOP1 depletion and R-loop removal, single lab","pmids":["38375218"],"is_preprint":false},{"year":2024,"finding":"CDK1 phosphorylates TDP1 at residue S61 during mitosis to promote repair of trapped Top1cc (Top1-DNA covalent complexes); a TDP1-S61A phospho-deficient variant is trapped on mitotic chromosomes and causes DNA damage and mitotic defects; Top1cc repair in mitosis occurs through a MUS81-dependent mechanism; replication stress leads to TDP1-S61A enrichment at common fragile sites, causing MUS81-dependent chromatid breaks, anaphase bridges and micronuclei.","method":"Identification of CDK1 phosphorylation site by mutagenesis, phospho-deficient TDP1-S61A cell lines, mitotic chromosome imaging, MUS81 epistasis, camptothecin/aphidicolin treatment","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — phosphorylation site identified and validated by mutagenesis, multiple cellular phenotypes, pathway placed via MUS81 epistasis","pmids":["39014228"],"is_preprint":false},{"year":2025,"finding":"TOP1 resistance mutations (S57C, R364H, W401C, G359E) arising in metastatic breast cancer patients after ADC treatment show reduced enzymatic activity, attenuated covalent DNA binding, and resistance to TOP1 inhibitor payloads SN-38 and deruxtecan, establishing these as gain-of-function resistance alleles at structurally important positions.","method":"Plasma-based genotyping from patients progressing on ADC therapy, functional characterisation of recombinant TOP1 mutant proteins (enzymatic activity, covalent DNA binding, drug resistance assays)","journal":"Clinical cancer research","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro biochemical characterisation of patient-derived mutant proteins with multiple functional assays","pmids":["39745368"],"is_preprint":false},{"year":2018,"finding":"Human TOP1 residues 236 and 237 are required for interaction with BTBD2 (and BTBD1); replacement of these residues with the African Green Monkey counterparts abolishes both the infectivity enhancement of progeny HIV-1 virions and the TOP1-BTBD2 interaction, suggesting TOP1 modulates HIV-1 viral tropism through its interaction with BTBD2 in cytoplasmic bodies.","method":"Co-immunoprecipitation of TOP1 with BTBD1/BTBD2, site-directed mutagenesis of TOP1 residues 236–237, HIV-1 infectivity assays in AGM and human cells, RNAi knockdown of BTBD2","journal":"Virology journal","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP + mutagenesis + RNAi phenotype, single lab, moderate functional follow-up","pmids":["21092135"],"is_preprint":false},{"year":2018,"finding":"The NORAD lncRNA assembles a topoisomerase complex (NARC1) containing TOP1, ALYREF, and the PRPF19-CDC5L complex through interaction with RBMX; depletion of NORAD or RBMX leads to chromosome segregation defects, reduced replication-fork velocity, and altered cell-cycle progression linked to TOP1 and PRPF19-CDC5L function; NORAD acts by modulating the ability of RBMX to assemble this ribonucleoprotein complex.","method":"RNA antisense purification combined with quantitative mass spectrometry, NORAD/RBMX depletion with phenotypic analysis (chromosome segregation, replication fork velocity, cell cycle), rescue experiments with RBMX-binding site deletion","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — biochemical purification identifying complex components validated by depletion and rescue with defined binding-site mutant, multiple functional readouts","pmids":["30150775"],"is_preprint":false},{"year":2015,"finding":"The ERCC1-XPF endonuclease together with RPA can cleave 3′-phosphotyrosyl bond nick DNA lesions mimicking Top1cc in vitro; ERCC1-XPF and RPA co-localize at CPT damage sites in vivo; NER factors including ERCC1-XPF, RPA, DNA polymerase δ, FEN1, and DNA ligase 1 together support repair synthesis of Top1-attached nick DNA lesions, establishing an NER-related repair pathway for Top1cc.","method":"In vitro nuclease activity assays on phosphotyrosyl-nick DNA substrate, EMSA, co-localization by immunofluorescence in CPT-treated cells, in vitro DNA repair synthesis reconstitution","journal":"Carcinogenesis","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of endonuclease activity and repair synthesis plus in vivo co-localization","pmids":["26025908"],"is_preprint":false},{"year":2026,"finding":"In vertebrate (chicken DT40) cells, TOP1 and TOP2 have complementary roles in DNA replication: depletion of TOP1 alone or inhibition of TOP2 alone does not impair replication fork progression, but combining TOP1 depletion with TOP2 inhibition nearly abolishes DNA replication, causing S-phase arrest and apoptosis; additionally, TOP2 poison etoposide (but not the TOP2 inhibitor ICRF193) in TOP1-depleted cells causes G1/early S-phase arrest, implicating TOP1 in replication initiation.","method":"Conditional TOP1 knockout in DT40 cells, ICRF193 (TOP2 inhibitor) and etoposide (TOP2 poison) treatment, DNA replication rate measurement, cell-cycle analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — conditional vertebrate knockout with pharmacological TOP2 inhibition, multiple complementary assays","pmids":["41791707"],"is_preprint":false},{"year":2002,"finding":"Top1 activity promotes repressed chromatin at the rDNA locus in S. cerevisiae: deletion of TOP1 causes increased histone acetylation at the rDNA locus similar to sir2 deletion; in both top1 and sir2 mutants, rDNA chromatin becomes more accessible.","method":"Chromatin accessibility assays and histone acetylation analysis at rDNA locus in top1Δ and sir2Δ yeast strains","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 — chromatin biochemistry in genetic mutants, single lab","pmids":["12215413"],"is_preprint":false},{"year":1999,"finding":"The t(11;20)(p15;q11) chromosomal translocation in therapy-related MDS produces a chimeric NUP98-TOP1 mRNA in which the N-terminal FXFG repeat region of NUP98 is fused in-frame to the body of TOP1 (from exon 8 onwards), identifying TOP1 as a recurrent translocation target in haematological malignancies; the NUP98 FXFG domain is separated from its RNA-binding domain by the breakpoint.","method":"Molecular cloning of translocation breakpoint, RT-PCR, sequencing of chimeric transcript","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 3 — cloning and characterisation of fusion gene, clinical samples, single study","pmids":["10556215"],"is_preprint":false},{"year":2025,"finding":"TOPORS, a SUMO E3 ligase/ubiquitin ligase, promotes SUMO1 modification (SUMOylation) of TOP1 in macrophages; knockdown of TOPORS reduces SUMO1-TOP1 levels and increases TOP1 protein and γH2AX (DNA damage marker) in ovalbumin-stimulated macrophages, indicating that TOPORS-mediated SUMO1 modification of TOP1 facilitates DNA damage repair in oxidative stress conditions.","method":"Immunoprecipitation to detect SUMO1-TOP1 conjugates, TOPORS knockdown (RNAi), γH2AX immunofluorescence, OVA-stimulated macrophage model","journal":"Toxicology letters","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP for modification + knockdown phenotype, single lab, limited mechanistic detail","pmids":["40532862"],"is_preprint":false}],"current_model":"Human TOP1 is a type IB topoisomerase that relieves DNA torsional stress by clamping around duplex DNA, nicking one strand via active-site Tyr-723, allowing controlled rotation of the downstream DNA, and religating the nick; camptothecin-class drugs intercalate at the cleavage site to trap the covalent TOP1-DNA cleavage complex (TOP1cc), which is repaired by TDP1 (direct hydrolysis of the phosphotyrosyl bond) or by redundant pathways including ERCC1-XPF/NER, MUS81 (after TOP1 proteolysis), and homologous recombination, with PARP1-mediated PARylation, CDK1-dependent TDP1 phosphorylation, and SUMO/ubiquitin modifications further regulating TOP1 dynamics and TOP1cc removal; TOP1 works cooperatively with TOP2 at replication forks and during transcription to prevent accumulation of supercoils and R-loops, and its abortive activity at ribonucleotides generates a distinctive deletion mutational signature contributing to cancer and germline instability."},"narrative":{"teleology":[{"year":1985,"claim":"Establishing that TOP1 is dispensable for viability as a single mutant but essential in the absence of TOP2 defined the cooperative, partially redundant relationship between the two topoisomerases in chromosome metabolism.","evidence":"Yeast TOP1 deletion and top1Δ top2-ts double-mutant viability assays","pmids":["2997777"],"confidence":"High","gaps":["Mechanistic basis of TOP1–TOP2 functional overlap at specific genomic loci was unknown","Whether TOP1 deletion affects replication fork dynamics was not addressed"]},{"year":1988,"claim":"Cloning of human TOP1 and mapping the catalytic activity to the C-terminal 67.7-kDa fragment containing Tyr-723 established the domain architecture and active-site residue of the human enzyme.","evidence":"cDNA cloning, in vitro DNA relaxation assay, proteolysis mapping","pmids":["2833744"],"confidence":"High","gaps":["No three-dimensional structure available","Mechanism of strand rotation after cleavage was unknown"]},{"year":1998,"claim":"Crystal structures of human TOP1 covalently and noncovalently bound to DNA revealed the clamp architecture, confirmed Tyr-723 as the active-site nucleophile, and led to the controlled-rotation model for DNA relaxation.","evidence":"X-ray crystallography at 2.1–2.8 Å of TOP1–DNA complexes","pmids":["9488644","9488652"],"confidence":"High","gaps":["Camptothecin binding site was inferred but not directly visualized","Open-to-closed conformational transition mechanism was not resolved"]},{"year":2002,"claim":"Identification of TDP1 and Rad1-Rad10 (ERCC1-XPF) as two redundant primary pathways for TOP1cc repair, both requiring downstream homologous recombination, established the framework for understanding TOP1cc-associated DNA damage responses.","evidence":"Yeast genetic epistasis with tdp1 rad1 double mutants, camptothecin sensitivity assays","pmids":["12368472"],"confidence":"High","gaps":["Whether additional nucleases contribute to TOP1cc removal was unknown","The role of proteasomal degradation of TOP1 before nucleolytic processing was not defined"]},{"year":2002,"claim":"The ternary crystal structure of TOP1–DNA–Topotecan directly showed that the camptothecin pharmacophore intercalates at the cleavage site to block religation, establishing the structural basis for uncompetitive TOP1 inhibition.","evidence":"X-ray crystallography of TOP1–DNA–Topotecan ternary complex","pmids":["12426403"],"confidence":"High","gaps":["Structural basis for newer inhibitors (e.g., exatecan) awaited direct crystallographic confirmation","How drug binding affects controlled rotation dynamics was not resolved"]},{"year":2007,"claim":"Genome-wide ChIP mapping showed TOP1 and TOP2 co-occupy a ~600 bp zone at replication forks; their combined loss but not single loss causes fork arrest and checkpoint activation, quantifying the redundancy at replication forks.","evidence":"ChIP genome-wide mapping of Top1/Top2 at replicating chromosomes in budding yeast, checkpoint kinase assays","pmids":["17671091"],"confidence":"High","gaps":["Whether TOP1 contributes specifically to replication initiation was not addressed","Vertebrate confirmation of fork-proximal co-occupancy was lacking"]},{"year":2008,"claim":"Discovery that TOP1 catalytic activity promotes a repressed chromatin state at telomere-proximal regions and rDNA broadened TOP1 function beyond supercoil relaxation to include chromatin organization.","evidence":"Microarray expression profiling, ChIP, and catalytic-dead Y727F mutant analysis in yeast","pmids":["18272174","12215413"],"confidence":"Medium","gaps":["Direct mechanism linking TOP1 catalysis to histone deacetylation was not identified","Whether this chromatin role is conserved in mammals was not tested"]},{"year":2015,"claim":"Biochemical reconstitution of ERCC1-XPF/RPA-mediated cleavage and repair synthesis on phosphotyrosyl-nick substrates established a complete NER-related repair pathway for TOP1cc in mammalian cells.","evidence":"In vitro nuclease assays on phosphotyrosyl-nick DNA, repair synthesis reconstitution, co-localization by immunofluorescence in CPT-treated cells","pmids":["26025908"],"confidence":"High","gaps":["Relative contribution of NER versus TDP1 in different cell types was not quantified","Whether this pathway operates during transcription-associated TOP1cc was not addressed"]},{"year":2016,"claim":"Demonstration that TOP1 performs ribonucleotide-dependent deletions via a sequential double-cleavage mechanism at tandem repeats defined the enzymatic basis of TOP1-mediated mutagenesis.","evidence":"In vitro TOP1 cleavage assays on defined substrates paralleled by in vivo yeast mutation assays","pmids":["27257064"],"confidence":"High","gaps":["Genome-wide prevalence of this mechanism in mammalian cells was not yet established","Whether deletion size is influenced by chromatin context was unknown"]},{"year":2016,"claim":"PARP1-mediated PARylation was shown to regulate TOP1 subnuclear dynamics, with PARP inhibition delocalizing TOP1 from the nucleolus and increasing genome-wide TOP1cc trapping, linking PARP activity to TOP1 function.","evidence":"Live-cell FRAP imaging, PARP inhibitor treatment, TOP1 mutagenesis (W205, N722S)","pmids":["27466387"],"confidence":"High","gaps":["Which specific TOP1 residue(s) are PARylated was not identified","Whether PARP inhibitor–TOP1 synergy is clinically exploitable beyond camptothecin was not tested"]},{"year":2018,"claim":"Identification of the NORAD lncRNA–RBMX–TOP1–PRPF19-CDC5L complex (NARC1) revealed that TOP1 participates in a ribonucleoprotein complex required for genome stability and normal replication fork progression.","evidence":"RNA antisense purification with quantitative mass spectrometry, NORAD/RBMX depletion phenotypic analysis, rescue with binding-site mutant","pmids":["30150775"],"confidence":"High","gaps":["Direct biochemical role of TOP1 within NARC1 was not dissected","Whether NARC1 function requires TOP1 catalytic activity was not tested"]},{"year":2019,"claim":"Identification of Apn2 as an additional nuclease resolving TOP1-derived 3′ adducts expanded the repertoire of TOP1cc repair enzymes beyond TDP1 and NER.","evidence":"In vitro biochemistry on defined 3′-adduct substrates and yeast epistasis with APN2, TDP1, RNH201 deletions","pmids":["30778235"],"confidence":"High","gaps":["Whether mammalian APE1/APE2 perform analogous TOP1cc resolution was not demonstrated","Relative flux through Apn2 versus TDP1 pathways in vivo was not quantified"]},{"year":2021,"claim":"Abraxas was shown to restrict SLX4/MUS81 recruitment to TOP1cc-derived single-ended DSBs, preventing excessive end resection and aberrant break-induced replication; this placed ubiquitin-dependent regulation at the center of TOP1cc-to-DSB processing.","evidence":"Isogenic knockouts of Abraxas, SLX4, MUS81, MRE11, CtIP, RAD52, POLD3 with CPT treatment and mitotic DNA synthesis readouts","pmids":["34272385"],"confidence":"High","gaps":["Which E3 ligase deposits the K63-ubiquitin chains counteracted by Abraxas was not identified","In vivo contribution to camptothecin drug response was not assessed"]},{"year":2022,"claim":"Mutational signature analysis in cancer genomes and mouse models established that TOP1 activity at genome-embedded ribonucleotides generates the characteristic ID4 deletion signature in both somatic and germline contexts, directly linking TOP1 catalysis to mutagenesis.","evidence":"Mutational signature analysis in cancer and germline data, mouse models with defective RER, TNT motif identification","pmids":["35140396"],"confidence":"High","gaps":["Whether TOP1-mediated mutagenesis rates vary across tissues or cell types was not resolved","Potential protective role of accessory helicases was not examined"]},{"year":2022,"claim":"Genome-wide CRISPR screens in TDP1-KO cells confirmed MUS81 as the key nuclease generating DSBs from unresolved TOP1cc, and revealed synthetic lethality between TDP1 and APEX1/2, refining the network of TOP1cc repair pathways.","evidence":"Unbiased CRISPR screen, isogenic TDP1/MUS81 and TDP1/APEX co-deficient cell lines, DSB quantification","pmids":["35869071"],"confidence":"High","gaps":["Whether APEX1/2 directly process TOP1cc or act indirectly was not determined","Pathway hierarchy under physiological versus drug-induced TOP1cc loads was not defined"]},{"year":2023,"claim":"Demonstration that transcription-associated TOP1cc generate DSBs and chromosomal translocations suppressed by TDP1 via an MRN/NHEJ-dependent pathway distinguished transcription-coupled TOP1 damage from replication-coupled damage.","evidence":"TDP1 depletion in human cells, translocation mapping, MRN and NHEJ genetic dissection","pmids":["37945566"],"confidence":"High","gaps":["Whether specific gene loci are predisposed to transcription-coupled TOP1 translocations was not systematically mapped","Contribution to therapy-related secondary malignancies was not directly tested"]},{"year":2024,"claim":"CDK1-mediated phosphorylation of TDP1 at S61 was shown to be required for efficient mitotic TOP1cc repair; failure of this regulation causes MUS81-dependent fragile-site breaks and chromosome missegregation, establishing cell-cycle-dependent regulation of TOP1cc resolution.","evidence":"TDP1-S61A phospho-deficient mutant cell lines, mitotic chromosome imaging, MUS81 epistasis, CPT/aphidicolin treatment","pmids":["39014228"],"confidence":"High","gaps":["Whether additional CDK substrates in the TOP1cc repair network exist was not addressed","Mitotic TOP1cc repair was not evaluated in the context of therapeutic TOP1 inhibitors"]},{"year":2025,"claim":"Functional characterization of clinical TOP1 resistance mutations (S57C, R364H, W401C, G359E) arising under ADC therapy showed reduced catalytic activity and attenuated covalent DNA binding, defining mechanisms of acquired resistance to TOP1 inhibitor payloads.","evidence":"Recombinant mutant TOP1 proteins assayed for enzymatic activity, covalent DNA binding, and drug resistance; patient plasma genotyping","pmids":["39745368"],"confidence":"High","gaps":["Whether combination strategies can overcome these resistance alleles was not tested","Structural basis for resistance at each site lacks direct crystallographic data"]},{"year":null,"claim":"Key unresolved questions include: how TOP1 catalytic activity within the NARC1 RNP complex contributes to genome stability; the structural basis of the open-to-closed conformational transition in human TOP1; the relative pathway flux through TDP1, NER, and MUS81 routes under physiological versus drug-induced TOP1cc loads; and whether TOP1-mediated mutagenesis rates are tissue-specific.","evidence":"","pmids":[],"confidence":"Low","gaps":["No reconstitution of NARC1-dependent TOP1 function","No human TOP1 apo-form crystal structure","No quantitative in vivo measurement of pathway choice for TOP1cc repair"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,2,3,11]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,3,4]},{"term_id":"GO:0016853","term_label":"isomerase activity","supporting_discovery_ids":[0,3]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[10]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[10]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[6,7,9]}],"pathway":[{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[6,14,28,30]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[5,8,15,16,18,23,25,29]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,22,24]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7,31]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[19,26,32]}],"complexes":["NARC1 (NORAD-RBMX-TOP1-PRPF19-CDC5L)"],"partners":["TDP1","PARP1","MUS81","ERCC1","XPF","RBMX","TOF1","TOPORS"],"other_free_text":[]},"mechanistic_narrative":"TOP1 is a type IB DNA topoisomerase that relieves torsional stress generated during replication and transcription by clamping around duplex DNA, cleaving one strand via the active-site nucleophile Tyr-723 to form a covalent 3′-phosphotyrosyl intermediate (TOP1 cleavage complex, TOP1cc), allowing controlled rotation of the downstream duplex, and religating the nick [PMID:9488644, PMID:9488652]. TOP1 acts cooperatively with TOP2 within ~600 bp of replication forks and at replication initiation; loss of both topoisomerases arrests fork progression and activates the DNA damage checkpoint [PMID:17671091, PMID:41791707]. Camptothecin-class drugs trap the TOP1cc by intercalating at the cleavage site, and trapped complexes are resolved by redundant pathways including TDP1-mediated phosphotyrosyl hydrolysis, ERCC1-XPF/NER endonuclease cleavage, and MUS81-dependent processing after TOP1 proteolysis, with PARP1-dependent PARylation and SUMO/ubiquitin modifications further regulating TOP1cc dynamics and repair [PMID:12426403, PMID:12368472, PMID:26025908, PMID:37194054, PMID:27466387]. Abortive TOP1 activity at genome-embedded ribonucleotides generates a characteristic 2–5 bp deletion mutational signature (ID4) contributing to both somatic and germline mutagenesis, and transcription-coupled TOP1cc formation at hypertranscribed loci cooperates with R-loops to produce DSBs and chromosomal translocations [PMID:35140396, PMID:37945566, PMID:38375218]."},"prefetch_data":{"uniprot":{"accession":"P11387","full_name":"DNA topoisomerase 1","aliases":["DNA topoisomerase I"],"length_aa":765,"mass_kda":90.7,"function":"Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free DNA strand then rotates around the intact phosphodiester bond on the opposing strand, thus removing DNA supercoils. Finally, in the religation step, the DNA 5'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Involved in the circadian transcription of the core circadian clock component BMAL1 by altering the chromatin structure around the ROR response elements (ROREs) on the BMAL1 promoter","subcellular_location":"Nucleus, nucleolus; Nucleus, nucleoplasm","url":"https://www.uniprot.org/uniprotkb/P11387/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/TOP1","classification":"Common Essential","n_dependent_lines":1123,"n_total_lines":1208,"dependency_fraction":0.929635761589404},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000198900","cell_line_id":"CID001004","localizations":[{"compartment":"chromatin","grade":3},{"compartment":"nucleoplasm","grade":1}],"interactors":[{"gene":"HNRNPA3","stoichiometry":10.0},{"gene":"HNRNPA2B1","stoichiometry":10.0},{"gene":"EIF4A3","stoichiometry":10.0},{"gene":"RBMX;RBMXL2","stoichiometry":10.0},{"gene":"HNRNPA1;HNRNPA1L2","stoichiometry":10.0},{"gene":"TRA2B","stoichiometry":10.0},{"gene":"ERH","stoichiometry":10.0},{"gene":"PARP1","stoichiometry":4.0},{"gene":"TOX4;TOX3;TOX2;TOX","stoichiometry":4.0},{"gene":"H2AFY","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001004","total_profiled":1310},"omim":[{"mim_id":"620608","title":"TESTIS-EXPRESSED GENE 264; TEX264","url":"https://www.omim.org/entry/620608"},{"mim_id":"617037","title":"NONCODING RNA ACTIVATED BY DNA DAMAGE; NORAD","url":"https://www.omim.org/entry/617037"},{"mim_id":"616761","title":"SUSHI DOMAIN-CONTAINING PROTEIN 6; SUSD6","url":"https://www.omim.org/entry/616761"},{"mim_id":"616259","title":"SMALL NUCLEOLAR RNA HOST GENE 14; SNHG14","url":"https://www.omim.org/entry/616259"},{"mim_id":"616086","title":"SprT-LIKE N-TERMINAL DOMAIN PROTEIN; SPRTN","url":"https://www.omim.org/entry/616086"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli fibrillar center","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TOP1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P11387","domains":[{"cath_id":"1.10.10.41","chopping":"239-318","consensus_level":"high","plddt":97.264,"start":239,"end":318},{"cath_id":"2.170.11.10","chopping":"322-430","consensus_level":"high","plddt":97.0951,"start":322,"end":430},{"cath_id":"3.90.15.10","chopping":"435-583","consensus_level":"medium","plddt":96.8256,"start":435,"end":583},{"cath_id":"1.10.132.10","chopping":"595-757","consensus_level":"medium","plddt":94.4464,"start":595,"end":757}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11387","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11387-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11387-F1-predicted_aligned_error_v6.png","plddt_mean":80.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TOP1","jax_strain_url":"https://www.jax.org/strain/search?query=TOP1"},"sequence":{"accession":"P11387","fasta_url":"https://rest.uniprot.org/uniprotkb/P11387.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11387/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11387"}},"corpus_meta":[{"pmid":"12368472","id":"PMC_12368472","title":"Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12368472","citation_count":182,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2997777","id":"PMC_2997777","title":"Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II.","date":"1985","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2997777","citation_count":163,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17671091","id":"PMC_17671091","title":"Top1- and Top2-mediated topological transitions at replication forks ensure fork progression and stability and prevent DNA damage checkpoint activation.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17671091","citation_count":135,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2181275","id":"PMC_2181275","title":"HPR1, a novel yeast gene that prevents intrachromosomal excision recombination, shows carboxy-terminal homology to the Saccharomyces cerevisiae TOP1 gene.","date":"1990","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2181275","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26287259","id":"PMC_26287259","title":"Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy.","date":"2015","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/26287259","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10556215","id":"PMC_10556215","title":"The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10556215","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12004060","id":"PMC_12004060","title":"The origin recognition complex marks a replication origin in the human TOP1 gene promoter.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12004060","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35140396","id":"PMC_35140396","title":"Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.","date":"2022","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/35140396","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22536944","id":"PMC_22536944","title":"Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.","date":"2012","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22536944","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15386001","id":"PMC_15386001","title":"Analgesia: morphine-pathway block in top1 poppies.","date":"2004","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15386001","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25522766","id":"PMC_25522766","title":"Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecan.","date":"2014","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25522766","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27466387","id":"PMC_27466387","title":"Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27466387","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26312433","id":"PMC_26312433","title":"Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.","date":"2015","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26312433","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23259865","id":"PMC_23259865","title":"Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).","date":"2012","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23259865","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20215517","id":"PMC_20215517","title":"Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20215517","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20170702","id":"PMC_20170702","title":"TOP1 and 2, polysaccharides from Taraxacum officinale, attenuate CCl(4)-induced hepatic damage through the modulation of NF-kappaB and its regulatory mediators.","date":"2010","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/20170702","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31409613","id":"PMC_31409613","title":"The Indenoisoquinoline TOP1 Inhibitors Selectively Target Homologous Recombination-Deficient and Schlafen 11-Positive Cancer Cells and Synergize with Olaparib.","date":"2019","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/31409613","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21408210","id":"PMC_21408210","title":"SUMO-targeted ubiquitin ligase, Rad60, and Nse2 SUMO ligase suppress spontaneous Top1-mediated DNA damage and genome instability.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21408210","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25811317","id":"PMC_25811317","title":"Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.","date":"2015","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25811317","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35439320","id":"PMC_35439320","title":"TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor.","date":"2022","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/35439320","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30336023","id":"PMC_30336023","title":"Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.","date":"2018","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30336023","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35869071","id":"PMC_35869071","title":"TDP1-independent pathways in the process and repair of TOP1-induced DNA damage.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35869071","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33981998","id":"PMC_33981998","title":"Top1-PARP1 association and beyond: from DNA topology to break repair.","date":"2021","source":"NAR cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33981998","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11016837","id":"PMC_11016837","title":"Genetic analysis of the Saccharomyces cerevisiae Sgs1 helicase defines an essential function for the Sgs1-Top3 complex in the absence of SRS2 or TOP1.","date":"2000","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/11016837","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24004003","id":"PMC_24004003","title":"The Arabidopsis oligopeptidases TOP1 and TOP2 are salicylic acid targets that modulate SA-mediated signaling and the immune response.","date":"2013","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24004003","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38709212","id":"PMC_38709212","title":"Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer.","date":"2024","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/38709212","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28641942","id":"PMC_28641942","title":"The Top1 paradox: Friend and foe of the eukaryotic genome.","date":"2017","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/28641942","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18272174","id":"PMC_18272174","title":"Global transcription regulation by DNA topoisomerase I in exponentially growing Saccharomyces cerevisiae cells: activation of telomere-proximal genes by TOP1 deletion.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18272174","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37108395","id":"PMC_37108395","title":"Resistance to TOP-1 Inhibitors: Good Old Drugs Still Can Surprise Us.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37108395","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28337384","id":"PMC_28337384","title":"Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?","date":"2017","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28337384","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30778235","id":"PMC_30778235","title":"Apn2 resolves blocked 3' ends and suppresses Top1-induced mutagenesis at genomic rNMP sites.","date":"2019","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30778235","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25232464","id":"PMC_25232464","title":"TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to Topotecan.","date":"2014","source":"Journal of cancer science & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25232464","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34439157","id":"PMC_34439157","title":"Effect of Pterostilbene, a Natural Derivative of Resveratrol, in the Treatment of Colorectal Cancer through Top1/Tdp1-Mediated DNA Repair Pathway.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34439157","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29290109","id":"PMC_29290109","title":"Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.","date":"2018","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29290109","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25830313","id":"PMC_25830313","title":"Genome-destabilizing effects associated with top1 loss or accumulation of top1 cleavage complexes in yeast.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25830313","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22171973","id":"PMC_22171973","title":"TOP1 gene copy numbers in colorectal cancer samples and cell lines and their association to in vitro drug sensitivity.","date":"2012","source":"Scandinavian journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/22171973","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26025908","id":"PMC_26025908","title":"Repair synthesis step involving ERCC1-XPF participates in DNA repair of the Top1-DNA damage complex.","date":"2015","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/26025908","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17360915","id":"PMC_17360915","title":"Seizure suppression by top1 mutations in Drosophila.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17360915","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39745368","id":"PMC_39745368","title":"TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.","date":"2025","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/39745368","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23577133","id":"PMC_23577133","title":"Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23577133","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34008967","id":"PMC_34008967","title":"Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34008967","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35013228","id":"PMC_35013228","title":"Topoisomerase I (TOP1) dynamics: conformational transition from open to closed states.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35013228","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30267816","id":"PMC_30267816","title":"A polysaccharide from Antrodia cinnamomea mycelia exerts antitumor activity through blocking of TOP1/TDP1-mediated DNA repair pathway.","date":"2018","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30267816","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24574527","id":"PMC_24574527","title":"Reversible Top1 cleavage complexes are stabilized strand-specifically at the ribosomal replication fork barrier and contribute to ribosomal DNA stability.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24574527","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35957613","id":"PMC_35957613","title":"Immunogenicity of small-cell lung cancer associates with STING pathway activation and is enhanced by ATR and TOP1 inhibition.","date":"2022","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35957613","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19931604","id":"PMC_19931604","title":"Relations between strain and gender dependencies of irinotecan toxicity and UGT1A1, CES2 and TOP1 expressions in mice.","date":"2009","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/19931604","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12215413","id":"PMC_12215413","title":"Acetylation and accessibility of rDNA chromatin in Saccharomyces cerevisiae in (Delta)top1 and (Delta)sir2 mutants.","date":"2002","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12215413","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33144457","id":"PMC_33144457","title":"Implications of Topoisomerase (TOP1 and TOP2α) Expression in Patients With Breast Cancer.","date":"2020","source":"In vivo (Athens, Greece)","url":"https://pubmed.ncbi.nlm.nih.gov/33144457","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32572188","id":"PMC_32572188","title":"Synthetic lethal targeting of TET2-mutant hematopoietic stem and progenitor cells (HSPCs) with TOP1-targeted drugs and PARP1 inhibitors.","date":"2020","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/32572188","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31636207","id":"PMC_31636207","title":"Deletions associated with stabilization of the Top1 cleavage complex in yeast are products of the nonhomologous end-joining pathway.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31636207","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34272385","id":"PMC_34272385","title":"Abraxas suppresses DNA end resection and limits break-induced replication by controlling SLX4/MUS81 chromatin loading in response to TOP1 inhibitor-induced DNA damage.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34272385","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29799191","id":"PMC_29799191","title":"Camptothecin Efficacy to Poison Top1 Is Altered by Bisphenol A in Mouse Embryonic Fibroblasts.","date":"2018","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/29799191","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16939812","id":"PMC_16939812","title":"Retroviral integration site analysis identifies ICSBP as a collaborating tumor suppressor gene in NUP98-TOP1-induced leukemia.","date":"2006","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/16939812","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32430490","id":"PMC_32430490","title":"The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2.","date":"2020","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/32430490","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38375218","id":"PMC_38375218","title":"TOP1 and R-loops facilitate transcriptional DSBs at hypertranscribed cancer driver genes.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38375218","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28961461","id":"PMC_28961461","title":"Effects of camptothecin or TOP1 overexpression on genetic stability in Saccharomyces cerevisiae.","date":"2017","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/28961461","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12874791","id":"PMC_12874791","title":"Both NUP98/TOP1 and TOP1/NUP98 transcripts are detected in a de novo AML with t(11;20)(p15;q11).","date":"2003","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12874791","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27257064","id":"PMC_27257064","title":"Parallel analysis of ribonucleotide-dependent deletions produced by yeast Top1 in vitro and in vivo.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27257064","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14505635","id":"PMC_14505635","title":"5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones and related compounds as TOP1-targeting agents: influence of structure on the ternary cleavable complex formation.","date":"2003","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/14505635","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11141172","id":"PMC_11141172","title":"Carrot cells contain two top1 genes having the coding capacity for two distinct DNA topoisomerases I.","date":"2000","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/11141172","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25615400","id":"PMC_25615400","title":"TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas.","date":"2015","source":"Scandinavian journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/25615400","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27872982","id":"PMC_27872982","title":"Interplay between Top1 and Mms21/Nse2 mediated sumoylation in stable maintenance of long chromosomes.","date":"2016","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27872982","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37945566","id":"PMC_37945566","title":"TDP1 suppresses chromosomal translocations and cell death induced by abortive TOP1 activity during gene transcription.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37945566","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11979559","id":"PMC_11979559","title":"Expression of NUP98/TOP1, but not of TOP1/NUP98, in a treatment-related myelodysplastic syndrome with t(10;20;11)(q24;q11;p15).","date":"2002","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11979559","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37194054","id":"PMC_37194054","title":"MUS81 cleaves TOP1-derived lesions and other DNA-protein cross-links.","date":"2023","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/37194054","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26042129","id":"PMC_26042129","title":"Dimerization and thiol sensitivity of the salicylic acid binding thimet oligopeptidases TOP1 and TOP2 define their functions in redox-sensitive cellular pathways.","date":"2015","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/26042129","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25885574","id":"PMC_25885574","title":"A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol.","date":"2015","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25885574","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39014228","id":"PMC_39014228","title":"TDP1 phosphorylation by CDK1 in mitosis promotes MUS81-dependent repair of trapped Top1-DNA covalent complexes.","date":"2024","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/39014228","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32028591","id":"PMC_32028591","title":"TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32028591","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39029901","id":"PMC_39029901","title":"Neopterin mediates sleep deprivation-induced microglial activation resulting in neuronal damage by affecting YY1/HDAC1/TOP1/IL-6 signaling.","date":"2024","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/39029901","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35942340","id":"PMC_35942340","title":"TOP1 CAD-seq: A protocol to map catalytically engaged topoisomerase 1 in human cells.","date":"2022","source":"STAR protocols","url":"https://pubmed.ncbi.nlm.nih.gov/35942340","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12645654","id":"PMC_12645654","title":"Generation of the NUP98-TOP1 fusion transcript by the t(11;20) (p15;q11) in a case of acute monocytic leukemia.","date":"2003","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/12645654","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26716562","id":"PMC_26716562","title":"Roles of DNA helicases and Exo1 in the avoidance of mutations induced by Top1-mediated cleavage at ribonucleotides in DNA.","date":"2015","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/26716562","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34560251","id":"PMC_34560251","title":"TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.","date":"2021","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/34560251","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28204881","id":"PMC_28204881","title":"Genetic evidence for functional interaction of Smc5/6 complex and Top1 with spatial frequency of replication origins required for maintenance of chromosome stability.","date":"2017","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28204881","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37890780","id":"PMC_37890780","title":"Atypical genotoxicity of carcinogenic nickel(II): Linkage to dNTP biosynthesis, DNA-incorporated rNMPs, and impaired repair of TOP1-DNA crosslinks.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37890780","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40102901","id":"PMC_40102901","title":"MicroRNA-24-3p targeting Top1 in perirenal fat is involved in circulating inflammation and high cardiovascular disease risk in patients with primary aldosteronism.","date":"2025","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40102901","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39106476","id":"PMC_39106476","title":"Discovery of Indolo[3,2-c]isoquinoline Derivatives as Novel Top1/2 Dual Inhibitors with Orally Efficacious Antitumor Activity and Low Toxicity.","date":"2024","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39106476","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34974222","id":"PMC_34974222","title":"TDP1 and TOP1 as targets in anticancer treatment of NSCLC: Activity and protein level in normal and tumor tissue from 150 NSCLC patients correlated to clinical data.","date":"2021","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/34974222","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31896687","id":"PMC_31896687","title":"Top1 and Top2 promote replication fork arrest at a programmed pause site.","date":"2020","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31896687","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36294786","id":"PMC_36294786","title":"Personalized Prescription of Chemotherapy Based on Assessment of mRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer.","date":"2022","source":"Journal of personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36294786","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36651963","id":"PMC_36651963","title":"Evolution of TOP1 and TOP1MT Topoisomerases in Chordata.","date":"2023","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/36651963","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24854867","id":"PMC_24854867","title":"Cloning of cDNAs for H1F0, TOP1, CLTA and CDK1 and the effects of cryopreservation on the expression of their mRNA transcripts in yak (Bos grunniens) oocytes.","date":"2014","source":"Cryobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24854867","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21092135","id":"PMC_21092135","title":"Human TOP1 residues implicated in species specificity of HIV-1 infection are required for interaction with BTBD2, and RNAi of BTBD2 in old world monkey and human cells increases permissiveness to HIV-1 infection.","date":"2010","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/21092135","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37587470","id":"PMC_37587470","title":"Integrated multi-omics analyses reveal Jorunnamycin A as a novel suppressor for muscle-invasive bladder cancer by targeting FASN and TOP1.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37587470","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28249294","id":"PMC_28249294","title":"Coexpression of NUP98/TOP1 and TOP1/NUP98 in de novo Acute Myeloid Leukemia with t(11;20)(p15;q12) and t(2;5)(q33;q31).","date":"2017","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/28249294","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35704193","id":"PMC_35704193","title":"Highly Purified Top1-Bound DNA Fragments.","date":"2022","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/35704193","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41145467","id":"PMC_41145467","title":"Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41145467","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40532862","id":"PMC_40532862","title":"Modulation of SUMO1-TOP1 DNA damage repair by TOPORS following ovalbumin-induced oxidative stress in macrophages.","date":"2025","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/40532862","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40971839","id":"PMC_40971839","title":"CRISPR/Cas9-mediated TOP1 knockout in chicken DF-1 cells reveals its critical role in apoptosis regulation and genomic stability.","date":"2026","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/40971839","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1977141","id":"PMC_1977141","title":"A three allele TaqI polymorphism at TOP1 gene.","date":"1990","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1977141","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7476870","id":"PMC_7476870","title":"Assembly of nucleosomal DNA in a cell-free extract from wild-type and top1- strains of Ustilago maydis.","date":"1995","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/7476870","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40839989","id":"PMC_40839989","title":"Compound Kushen Injection suppresses multiple myeloma progression via TOP1-targeted coordination of DNA damage and endoplasmic reticulum stress.","date":"2025","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40839989","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35844787","id":"PMC_35844787","title":"TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35844787","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41791707","id":"PMC_41791707","title":"TOP1 and TOP2 complementarily maintain DNA replication fork progression in vertebrates.","date":"2026","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41791707","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37456162","id":"PMC_37456162","title":"Protective effects of hsa_circ_0072568 on interleukin‑1β‑stimulated human chondrocytes are mediated via the miR‑382‑5p/TOP1 axis.","date":"2023","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37456162","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33791014","id":"PMC_33791014","title":"Critical roles of Rad54 in tolerance to apigenin-induced Top1-mediated DNA damage.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33791014","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"42019467","id":"PMC_42019467","title":"Activation of an adaptive antitumor immune response by the polymeric fluoropyrimidine CF10 involves TS/Top1 dual targeting.","date":"2026","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/42019467","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40906370","id":"PMC_40906370","title":"Discovery of Novel Drug-Conjugate Molecule ZM484 with Dual p53-MDM2 and TOP1 Inhibition for the Treatment of Colorectal Cancer.","date":"2025","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40906370","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41631794","id":"PMC_41631794","title":"LNP-Mediated CF10 Delivery Selectively Enhances Potency to Colorectal Cancer Cells and Preserves the TS/Top1 Dual Targeting Mechanism.","date":"2026","source":"ACS applied bio materials","url":"https://pubmed.ncbi.nlm.nih.gov/41631794","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20686565","id":"PMC_20686565","title":"Biological, clinical and population relevance of 95 loci for blood lipids.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20686565","citation_count":2873,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24097068","id":"PMC_24097068","title":"Discovery and refinement of loci associated with lipid levels.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24097068","citation_count":2409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22681889","id":"PMC_22681889","title":"The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22681889","citation_count":973,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15635413","id":"PMC_15635413","title":"Nucleolar proteome dynamics.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15635413","citation_count":934,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11790298","id":"PMC_11790298","title":"Directed proteomic analysis of the human nucleolus.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11790298","citation_count":780,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9488644","id":"PMC_9488644","title":"Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9488644","citation_count":698,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12426403","id":"PMC_12426403","title":"The mechanism of topoisomerase I poisoning by a camptothecin analog.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12426403","citation_count":627,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9488652","id":"PMC_9488652","title":"A model for the mechanism of human topoisomerase I.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9488652","citation_count":585,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20504901","id":"PMC_20504901","title":"The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3.","date":"2010","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/20504901","citation_count":541,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28302793","id":"PMC_28302793","title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28302793","citation_count":533,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20020773","id":"PMC_20020773","title":"Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.","date":"2010","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/20020773","citation_count":422,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28319085","id":"PMC_28319085","title":"Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.","date":"2017","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28319085","citation_count":378,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30150775","id":"PMC_30150775","title":"The NORAD lncRNA assembles a topoisomerase complex critical for genome stability.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/30150775","citation_count":298,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2833744","id":"PMC_2833744","title":"cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2833744","citation_count":292,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21903422","id":"PMC_21903422","title":"Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.","date":"2011","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/21903422","citation_count":286,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47161,"output_tokens":6616,"usd":0.120361},"stage2":{"model":"claude-opus-4-6","input_tokens":10252,"output_tokens":4432,"usd":0.24309},"total_usd":0.78277,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":58951,"output_tokens":9337,"usd":0.158454},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":12967,"output_tokens":4363,"usd":0.260865}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1985,\n      \"finding\": \"Yeast TOP1 encodes a functional DNA topoisomerase I; deletion of TOP1 eliminates all topoisomerase I activity in cell extracts, and top1 top2-ts double mutants are inviable under restrictive conditions, establishing Top1 as auxiliary to Top2 for cell viability in yeast.\",\n      \"method\": \"Immunological screening of genomic library, insertion/deletion mutagenesis, cell extract activity assay, temperature-shift experiments with synchronous cultures\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct gene deletion with in vitro activity assay and genetic epistasis, foundational paper with 163 citations\",\n      \"pmids\": [\"2997777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Yeast Tdp1 and the structure-specific endonuclease Rad1-Rad10 function as primary alternative pathways for repair of covalent Top1-DNA cleavage complexes (Top1cc); cells lacking both are highly sensitive to camptothecin and show TOP1-dependent growth delay; both repair routes depend on RAD52, RAD51, and RAD50 recombination.\",\n      \"method\": \"Genetic epistasis analysis, camptothecin sensitivity assays, double/triple mutant construction in S. cerevisiae\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — extensive genetic epistasis with multiple mutant combinations, replicated across multiple repair pathways, 182 citations\",\n      \"pmids\": [\"12368472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Top1 and Top2 act coordinately within a ~600 bp region spanning moving replication forks to relieve torsional stress; TOP1 ablation alone does not impair fork progression or activate the Rad53 checkpoint, but top1 top2 double mutants exhibit fork block, DNA damage checkpoint activation (Rad53 and γH2A phosphorylation), and fork processing dependent on Exo1.\",\n      \"method\": \"ChIP-on-chip to map Top1/Top2 on replicating chromosomes, genetic epistasis with checkpoint mutants, 2D gel electrophoresis of replication intermediates\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ChIP, genetics, checkpoint assays), 135 citations\",\n      \"pmids\": [\"17671091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PARP1-mediated poly(ADP-ribose) (PAR) modification of Top1 regulates its subnuclear dynamics; PARP inhibitors delocalize Top1 from nucleolus to nucleoplasm and increase the immobile/bound fraction of Top1 cleavage complexes (Top1cc) upon camptothecin treatment; Top1 residues Trp205 and Asn722 are critical for subnuclear dynamics, and N722S mutation restricts Top1 to the nucleolus.\",\n      \"method\": \"Live-cell imaging of GFP-tagged human Top1, FRAP with kinetic modeling, PARP inhibitor treatment, site-directed mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — live imaging + FRAP + mutagenesis in one study, multiple orthogonal methods\",\n      \"pmids\": [\"27466387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TOP1 activity at sites of genome-embedded ribonucleotides generates short 2–5 bp deletions (ID4 mutation signature) through a transcription-associated mutagenesis mechanism; defective ribonucleotide excision repair in mammals is associated with the ID4 signature at TNT sequence motifs, implicating TOP1 cleavage at rNMPs as the mechanistic basis.\",\n      \"method\": \"Mutational signature analysis in RER-deficient mammalian cells, genetic experiments with TOP1 depletion, genome sequencing\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic depletion of TOP1 combined with genome-wide mutation profiling, replicated in cancer and germline, 73 citations\",\n      \"pmids\": [\"35140396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MUS81 is an important factor that mediates the generation of excess double-strand breaks (DSBs) in TDP1-knockout cells after TOP1 poisoning; APEX1/2 are synthetically lethal with TDP1 but do not reduce DSB formation in TDP1-KO cells; TOP1cc can be resolved directly by TDP1 or converted into DSBs repaired by homologous recombination.\",\n      \"method\": \"Whole-genome CRISPR screens, generation of co-deficient cell lines, DSB formation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — unbiased genome-wide screen followed by genetic validation with multiple co-deficient lines\",\n      \"pmids\": [\"35869071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Structural analysis of archaeal CsTOP1 (ortholog of eukaryotic TOP1) revealed an open apo conformation resulting from rotation between capping (CAP) and catalytic (CAT) modules connected by a five-residue hinge loop; a conserved tyrosine near the hinge mediates the open-to-closed conformational transition upon DNA binding; hinge flexibility is required for camptothecin sensitivity.\",\n      \"method\": \"Crystal structure of apo-form CsTOP1, directed mutagenesis of hinge residues, camptothecin sensitivity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis validation of functional residues\",\n      \"pmids\": [\"35013228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In fission yeast, the SUMO-targeted ubiquitin ligase (STUbL) Rad60, and the SUMO E3 ligase Nse2 suppress spontaneous Top1-mediated DNA damage; cells with reduced STUbL activity accumulate Top1ccs (detected by ChIP-qPCR) and become dependent on Tdp1; STUbL/Rad60/Nse2 facilitate the Rad16-Swi10 (NER endonuclease) repair pathway for Top1cc removal.\",\n      \"method\": \"Genetic epistasis, chromatin immunoprecipitation with qPCR to detect Top1cc, checkpoint assay, camptothecin sensitivity\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct Top1cc detection by ChIP-qPCR plus extensive genetic epistasis\",\n      \"pmids\": [\"21408210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Top1-dependent deletion mutations at ribonucleotides in DNA occur by a sequential double-cleavage mechanism: Top1 incises at one rNMP, the enzyme-DNA intermediate realigns on a tandem repeat providing complementarity, and Top1-mediated ligation of the misaligned nick produces deletion; deletion size is determined by the distance between two Top1 cleavage sites.\",\n      \"method\": \"Parallel in vitro biochemical reconstitution with purified Top1 and in vivo yeast genetic assays, with systematic variation of repeat length and rNMP position\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — parallel in vitro reconstitution and in vivo genetic analysis with mechanistic mutagenesis\",\n      \"pmids\": [\"27257064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In yeast, Top1cc-dependent large deletions (~100 bp median) with minimal junction homology are produced by the nonhomologous end-joining (NHEJ) pathway, require Top1cc removal from DNA ends, and accumulate in quiescent cells, indicating that causative DSBs arise outside the context of replication.\",\n      \"method\": \"Genetic analysis of deletion junctions, NHEJ pathway mutants, camptothecin/top1-T722A stabilization of Top1cc in quiescent cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with NHEJ mutants plus molecular characterization of deletion junctions\",\n      \"pmids\": [\"31636207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Yeast Apn2 (AP endonuclease 2) resolves 3'-phosphotyrosine conjugates (Top1cc), 2',3'-cyclic phosphates, and their hydrolyzed products generated during Top1-mediated cleavage at rNMPs; APN2 deletion in RNH201-deficient cells increases 2-bp slippage mutagenesis.\",\n      \"method\": \"Genetic analysis, in vitro biochemical assays with purified Apn2 on Top1cc substrates\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of Apn2 activity on defined Top1cc substrates plus genetic validation\",\n      \"pmids\": [\"30778235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ERCC1-XPF endonuclease and RPA participate in repair of Top1-attached nick DNA lesions (3'-phosphotyrosyl bond nicks); ERCC1-XPF shows nuclease activity on Tyr-nick DNA substrates in the presence of RPA; ERCC1-XPF and RPA co-localize at CPT-induced damage sites in vivo, and repair synthesis of Tyr-nick DNA occurs with NER factors including ERCC1-XPF, RPA, Polδ, FEN1, and DNA ligase 1.\",\n      \"method\": \"In vitro nuclease assay on defined Tyr-nick DNA substrates, EMSA, immunofluorescence co-localization, repair synthesis assay in cell-free system\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro biochemical assay on defined substrates plus in vivo co-localization\",\n      \"pmids\": [\"26025908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Reversible Top1 cleavage complexes are specifically stabilized at the ribosomal DNA replication fork barrier (rRFB) in a strand-specific and replication-independent manner; this requires Fob1 and Tof2 proteins; these Top1ccs are reversible (not subject to Tdp1/Mus81 repair) and correlate with Top1-dependent rDNA stability.\",\n      \"method\": \"ChIP-qPCR to detect Top1ccs at rDNA loci, ectopically engineered rRFBs, genetic analysis of Fob1/Tof2/Tdp1/Mus81 mutants\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct Top1cc detection by ChIP combined with genetic epistasis and ectopic barrier engineering\",\n      \"pmids\": [\"24574527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MUS81 can cleave DNA-protein crosslinks (DPCs) including partially degraded/dislodged TOP1; native (full-size) TOP1 must be dislodged or partially degraded prior to MUS81 cleavage; TDP1 and MUS81 play independent roles in repair of camptothecin-induced TOP1 lesions.\",\n      \"method\": \"In vitro MUS81 cleavage assays on fluorescein/streptavidin/proteolytically processed TOP1 substrates, nuclear extract assays, MUS81-KO and TDP1-KO cell camptothecin sensitivity assays\",\n      \"journal\": \"BMC biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution with defined substrates plus genetic validation in KO cells\",\n      \"pmids\": [\"37194054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CDK1 phosphorylates TDP1 at residue S61 during mitosis; TDP1-S61A variant is trapped on mitotic chromosomes and causes DNA damage and mitotic defects; Top1cc repair during mitosis occurs via a MUS81-dependent mechanism; replication stress causes TDP1-S61A enrichment at common fragile sites, leading to MUS81-dependent chromatid breaks and anaphase bridges.\",\n      \"method\": \"Phosphorylation identification (CDK1 kinase assay, mass spectrometry), phospho-deficient mutant (TDP1-S61A) expression, immunofluorescence on mitotic chromosomes, MUS81 genetic analyses\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — CDK1 kinase assay identifies PTM site, mutagenesis validates functional consequence, MUS81 epistasis\",\n      \"pmids\": [\"39014228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Abraxas restricts SLX4/MUS81 recruitment to camptothecin-induced TOP1 damage sites by counteracting K63-linked ubiquitin modification; uncontrolled SLX4/MUS81 loading and excessive end resection via MRE11, CtIP, and DNA2/BLM leads to increased break-induced replication (BIR) via RAD52/POLD3-dependent, RAD51-independent pathway and chromosome aberrations.\",\n      \"method\": \"Co-IP, ubiquitin modification assays, genetic KO of Abraxas/SLX4/MUS81, mitotic DNA synthesis quantification, chromosome aberration analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus genetic epistasis with multiple pathway mutants\",\n      \"pmids\": [\"34272385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Abortive TOP1 activity generates permanent protein-linked single-strand breaks that, during transcription, can become double-strand breaks (DSBs); TDP1 suppresses chromosomal translocations arising from these transcription-associated DSBs; the translocation pathway relies on the MRN complex and canonical NHEJ.\",\n      \"method\": \"DSB mapping, R-loop and TOP1cc co-mapping, TDP1-knockout cells, chromosome translocation assays, NHEJ/MRN genetic epistasis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple mapping approaches combined with genetic epistasis and chromosome rearrangement readout\",\n      \"pmids\": [\"37945566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DSBs occur at highly transcribed genes enriched with TOP1 and R-loops; depletion of R-loops and TOP1 significantly reduces transcription-associated DSBs at these loci, establishing that TOP1 and R-loops are pivotal for transcriptional DSB formation.\",\n      \"method\": \"DSB mapping (BLESS/END-seq), R-loop mapping (DRIP-seq), TOP1cc mapping, TOP1 depletion\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple genomic mapping methods, but single study without full mechanistic reconstitution\",\n      \"pmids\": [\"38375218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Top1p binds to and is catalytically active at telomeric DNA repeats in yeast; deletion of TOP1 or catalytic point mutant Y727F increases H4 histone acetylation at the rDNA locus and at telomere-proximal regions, while Y727F (but not deletion alone) alters H3K4 dimethylation at subtelomeric gene 3' ends, indicating that Top1 catalytic activity regulates chromatin organization at these loci.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for Top1p and histone modifications, TOP1 deletion and catalytic point mutant (Y727F) strains, expression profiling\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with catalytic mutant comparison, single study\",\n      \"pmids\": [\"18272174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Absence of Top1p in yeast increases histone acetylation and chromatin accessibility at the rDNA locus in a manner similar to Sir2 deletion, linking Top1 to rDNA chromatin compaction.\",\n      \"method\": \"Chromatin accessibility assay, histone acetylation analysis by immunoprecipitation in top1 and sir2 deletion strains\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single study, indirect chromatin measurement without direct Top1-chromatin interaction assay\",\n      \"pmids\": [\"12215413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A t(11;20)(p15;q11) chromosomal translocation in therapy-related MDS fuses the NUP98 N-terminal FXFG repeat domain to the body of human TOP1, generating a NUP98-TOP1 chimeric mRNA/protein; the breakpoint on chromosome 20 occurs within TOP1 intron 7.\",\n      \"method\": \"Cloning of translocation breakpoints, RT-PCR detection of chimeric mRNA, sequence analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — molecular cloning and sequencing of fusion transcript, but mechanistic function of chimera not fully characterized in this paper\",\n      \"pmids\": [\"10556215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Human TOP1 residues 236 and 237 are required for TOP1 interaction with BTBD2 (and BTBD1); replacement of these residues with AGM counterparts abolishes both the TOP1-BTBD2 interaction and TOP1's ability to enhance HIV-1 virion infectivity when expressed in producer cells.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis of TOP1 residues 236/237, HIV-1 infectivity assay with RNAi knockdown of BTBD2\",\n      \"journal\": \"Virology journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP with mutagenesis, single study, limited mechanistic follow-up on TOP1 enzymatic function\",\n      \"pmids\": [\"21092135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In yeast, loss of Top1 does not destabilize single-copy genomic regions but causes increased instability in tandemly repeated rDNA and CUP1 arrays; stabilization of Top1cc (by camptothecin or top1-T722A allele) causes 5–10-fold increased reciprocal crossovers and greatly elevated rDNA/CUP1 instability, with lesions introduced during or after DNA synthesis.\",\n      \"method\": \"Sectoring assay for loss of heterozygosity, chromosome microarray characterization of crossover events, long-term subculturing genome stability assay\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic analysis with molecular characterization of individual events, single lab\",\n      \"pmids\": [\"25830313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The fork protection complex subunit Tof1-Csm3 physically interacts with Top1 through Tof1's C-terminal domain at replication forks; fork pausing at the rDNA replication fork barrier is impaired in the absence of Top1 or in a tof1 mutant that cannot bind Top1; Top2 can partially compensate for Top1 in this pausing function.\",\n      \"method\": \"Physical interaction (co-IP/two-hybrid), genetic analysis of fork pausing at rDNA RFB with top1 and tof1 mutants\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — physical interaction plus genetic epistasis, described in a commentary/perspective format but based on primary data from referenced study\",\n      \"pmids\": [\"31896687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Cell-free extracts from Ustilago maydis top1-deficient strains fail to catalyze nucleosome assembly-dependent DNA supercoiling; addition of purified topoisomerase I (and, to a lesser extent, topoisomerase II) to top1- extracts restores supercoiling activity, directly implicating Top1 in nucleosome assembly.\",\n      \"method\": \"In vitro nucleosome assembly and supercoiling assay with cell-free extracts, complementation with purified topoisomerase I\",\n      \"journal\": \"Molecular & general genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified enzyme complementation, but single study in Ustilago\",\n      \"pmids\": [\"7476870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TOPORS acts as a SUMO E3 ligase that mediates SUMO1 modification of TOP1 in macrophages under oxidative stress (OVA stimulation); knockdown of TOPORS reduces SUMO1-TOP1 levels but increases total TOP1 and γH2AX, indicating that SUMO1-TOP1 modification by TOPORS is required for efficient DNA damage repair.\",\n      \"method\": \"Co-immunoprecipitation for SUMO1-TOP1, siRNA knockdown of TOPORS, γH2AX as DNA damage readout in macrophages\",\n      \"journal\": \"Toxicology letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP study with limited mechanistic depth, no in vitro sumoylation reconstitution\",\n      \"pmids\": [\"40532862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Nickel(II) impairs SUMOylation and K48-polyubiquitination of DNA-crosslinked TOP1, detected by DPC-trap assay, by downregulating specific enzymes in these modification pathways, leading to accumulation of TOP1 DNA-protein crosslinks and genome instability.\",\n      \"method\": \"DPC-trap assay, fluorescent rNMP incorporation assay, Western blot for SUMO/ubiquitin modifications of crosslinked TOP1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single study, indirect measurement of modification pathway impairment without reconstitution\",\n      \"pmids\": [\"37890780\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human/eukaryotic TOP1 is a type IB topoisomerase that relieves DNA torsional stress by transiently nicking and resealing one DNA strand via a covalent 3'-phosphotyrosyl intermediate (Top1 cleavage complex, Top1cc); it acts in a ~600 bp window at moving replication forks complementarily with TOP2 to prevent supercoil and sister-chromatid entanglement accumulation, is regulated by PARP1-mediated PARylation and SUMO/ubiquitin modifications that control its subnuclear dynamics and proteasomal degradation, and its abortive Top1cc intermediates—stabilized by camptothecins, ribonucleotides in DNA, or oxidative stress—are repaired through at least two main pathways (TDP1-mediated direct hydrolysis of the phosphotyrosyl bond, and structure-specific endonucleases Rad1-Rad10/ERCC1-XPF or MUS81 that cleave the flanking DNA), with unrepaired Top1ccs generating DSBs during replication and transcription that are channeled into homologous recombination or NHEJ and can produce deletions, crossovers, and chromosomal translocations.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries from KEEP papers.\n\n**Classification notes:**\n- Papers [10] (opium poppy TOP1 mutant), [16] (Taraxacum polysaccharides TOP1/TOP2), [25] (Arabidopsis oligopeptidases TOP1/TOP2), [60] (carrot top1 genes), [66] (plant thimet oligopeptidases TOP1/TOP2) → EXCLUDE (symbol collision with plant/other organism genes unrelated to DNA topoisomerase I)\n- Papers from gene2pubmed additional set: [1],[2] (GWAS lipids), [3],[8] (mRNA interactome), [4] (cDNA library), [5],[6],[7],[12],[14],[24] (interactome/proteome studies - only relevant if they provide mechanistic TOP1 findings), [9],[11] (nucleolar proteome - mentions TOP1 localization), [10] (VIRMA/m6A), [13] DAXX histone chaperone), [15] (GO annotation), [19] (sulfonamide/RBM39), [20] (oligo-capping), [21] (OpenCell localization), [22] (TDP-43), [23] (alternative promoters), [25] (CRISPR GI screen), [26] (BioID map), [27] (CRL ubiquitin), [28] (NORAD lncRNA - mentions TOP1 in NARC1 complex), [29] (human TOP1 cDNA cloning - KEEP), [30] (innate immunity) → Most are large-scale proteomics with incidental TOP1 mentions; KEEP [28] and [29] as they have direct TOP1 mechanistic content; KEEP [21] for localization data.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"Human TOP1 was cloned from a cDNA library; the catalytically active domain resides in the C-terminal 67.7-kDa fragment (carboxyl terminus, including active-site Tyr-723), which relaxes supercoiled DNA in vitro and shares 42% identity with yeast Top1.\",\n      \"method\": \"cDNA cloning from λgt11 expression library, in vitro DNA relaxation assay, proteolysis mapping, immunoprecipitation with anti-topoisomerase I serum\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution of enzymatic activity + sequence validation + immunoprecipitation in a single foundational study\",\n      \"pmids\": [\"2833744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1985,\n      \"finding\": \"Yeast TOP1 (encoding DNA topoisomerase I) was cloned and shown to be a single-copy gene whose deletion is viable in haploid cells; however, combined deletion of TOP1 and the temperature-sensitive TOP2 is lethal even when mitotic arrest prevents TOP2-mediated death, demonstrating that TOP1 serves an auxiliary but distinct role in chromosome metabolism complementary to TOP2.\",\n      \"method\": \"Immunological screening of genomic library, construction of insertion/deletion mutants, cell viability assays, temperature-shift experiments with synchronised top1Δ top2-ts double mutants\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct genetic knockout with defined cellular phenotype, replicated across conditions\",\n      \"pmids\": [\"2997777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Crystal structures of human topoisomerase I (core + C-terminal domains) in covalent and noncovalent complexes with 22-bp DNA at 2.1 Å and 2.5 Å resolution reveal that the enzyme clamps around essentially B-form DNA; the active-site nucleophile Tyr-723 is in the C-terminal domain; the core domain shares structural similarity with phage integrases; a binding site for camptothecin at the enzyme-DNA interface was proposed.\",\n      \"method\": \"X-ray crystallography at 2.1 Å (noncovalent) and 2.5 Å (covalent) resolution\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structures of enzyme-DNA complexes, foundational study cited >600 times\",\n      \"pmids\": [\"9488644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Crystal structure of human TOP1 bound to a 22-bp DNA duplex (2.8 Å) revealed a coiled-coil linker domain protruding away from the enzyme-DNA interface; key catalytic residues were identified; the structure led to the 'controlled rotation' model for DNA relaxation, in which the downstream DNA rotates around the intact strand after Top1-mediated single-strand nicking.\",\n      \"method\": \"X-ray crystallography at 2.8 Å resolution of amino-terminally truncated TOP1–DNA complex\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mechanistic model validated against biochemical data, foundational study\",\n      \"pmids\": [\"9488652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"X-ray crystal structure of human topoisomerase I covalently joined to DNA and bound to the anticancer drug Topotecan (camptothecin analog) showed that Topotecan intercalates between the −1 and +1 base pairs at the cleavage site, displacing the downstream DNA and preventing religation, thereby acting as an uncompetitive inhibitor of the enzyme-substrate complex; direct drug contacts with TOP1 residues R364, D533, and N722 were identified.\",\n      \"method\": \"X-ray crystallography of ternary TOP1–DNA–Topotecan cleavage complex\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure of ternary complex directly explains camptothecin mechanism of action\",\n      \"pmids\": [\"12426403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In yeast, the tyrosyl-DNA phosphodiesterase Tdp1 and the structure-specific endonuclease Rad1-Rad10 function as two primary and redundant pathways for repairing TOP1 replicative damage (Top1 cleavage complexes at replication forks); both pathways require RAD52, RAD51, and RAD50 for subsequent recombination-dependent repair; double tdp1 rad1 mutants show TOP1-dependent growth delay and extreme camptothecin sensitivity.\",\n      \"method\": \"Yeast genetic epistasis analysis, camptothecin sensitivity assays, double-mutant construction including catalytic point mutants\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — extensive genetic epistasis with multiple alleles and double mutants, replicated across pathways\",\n      \"pmids\": [\"12368472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In S. cerevisiae, Top1 and Top2 act within a ~600 bp region spanning moving replication forks to relieve torsional stress; TOP1 ablation alone does not impair fork progression or activate the Rad53 checkpoint kinase, but top1 top2 double mutants exhibit fork block, processing, and phosphorylation of Rad53 and γH2A in S-phase, demonstrating a coordinated/redundant role of both topoisomerases at replication forks.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) genome-wide mapping of Top1 and Top2 on replicating chromosomes, genetic analysis of top1, top2 and top1 top2 mutants, checkpoint kinase assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP combined with genetic epistasis and defined molecular phenotypes\",\n      \"pmids\": [\"17671091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Deletion of TOP1 in yeast specifically increases transcription of telomere-proximal genes and alters histone modification: loss of Top1 or expression of an inactive Y727F Top1 mutant increases H4 histone acetylation at the rDNA locus and at telomere-proximal regions; immunoprecipitation showed Top1 binds telomeric DNA repeats and is catalytically active there, indicating that Top1 catalytic activity promotes a repressed chromatin state at subtelomeric regions.\",\n      \"method\": \"Gene expression microarrays, chromatin immunoprecipitation (ChIP), yeast deletion and catalytic-point mutant analysis\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + transcriptomics + catalytic mutant, single lab\",\n      \"pmids\": [\"18272174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The SUMO-targeted ubiquitin ligase (STUbL) Rad60 and the SUMO E3 ligase Nse2 suppress spontaneous Top1 cleavage complex (Top1cc) formation in fission yeast; cells with reduced STUbL activity are dependent on Tdp1 for viability, and detection of Top1ccs by ChIP-qPCR confirmed elevated Top1ccs in cells lacking Tdp1 combined with STUbL, Rad60 or Nse2 deficiency; epistasis analyses placed STUbL/Rad60/Nse2 in the Rad16-Swi10 (NER endonuclease) pathway for Top1cc repair.\",\n      \"method\": \"Genetic epistasis, ChIP-qPCR detection of Top1cc, camptothecin sensitivity assays, fission yeast genetics\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-qPCR quantification of Top1cc + epistasis, single lab\",\n      \"pmids\": [\"21408210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Reversible Top1 cleavage complexes (Top1ccs) are specifically stabilized strand-specifically at the ribosomal DNA replication fork barrier (rRFB) of budding yeast in a manner requiring Fob1 and Tof2 proteins; this stabilization is replication-independent, reversible (not subject to Tdp1 or Mus81 repair), and correlates with Top1-provided rDNA stability, establishing a novel physiologically regulated mode of Top1 action at the rRFB.\",\n      \"method\": \"ChIP at engineered and native rRFB loci, genetic analysis of fob1, tof2, tdp1, mus81 mutants, strand-specific detection of Top1cc\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with genetic validation and strand-specific assay, single lab\",\n      \"pmids\": [\"24574527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PARylation of Top1 by PARP1 regulates Top1 subnuclear dynamics: PARP inhibitors (Veliparib/ABT-888) delocalize Top1 from the nucleolus to the nucleoplasm independently of Top1-PARP1 direct interaction; PARP inhibition markedly increases the CPT-induced immobile (Top1cc) fraction of Top1 across the nuclear genome; Top1 residues Trp205 and Asn722 are critical for subnuclear dynamics; the N722S mutant is restricted to the nucleolus in CPT and is deficient in CPT-induced PARylation and Top1cc formation.\",\n      \"method\": \"Live-cell imaging with GFP-tagged Top1, fluorescence recovery after photobleaching (FRAP) with kinetic modelling, PARP inhibitor treatment, site-directed mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — live-cell FRAP + mutagenesis + kinetic modelling, multiple orthogonal methods in single study\",\n      \"pmids\": [\"27466387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Top1 performs ribonucleotide-dependent deletions via a sequential double-cleavage mechanism: Top1 incises at a ribonucleotide, forming a Top1cc, and a second Top1 cleavage event creates a gap; complementarity within a tandem repeat then promotes realignment and Top1-mediated ligation to generate a deletion; parallel in vitro and in vivo analyses confirmed that deletion size is determined by the distance between two Top1 cleavage sites, and downstream complementarity promotes deletion more effectively than upstream complementarity.\",\n      \"method\": \"Parallel in vitro Top1 cleavage assays with defined substrates and in vivo yeast mutation assays; deletion mapping\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro mechanism confirmed in parallel in vivo, mechanistic model directly tested\",\n      \"pmids\": [\"27257064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Apn2 (AP endonuclease 2) in S. cerevisiae resolves Top1-mediated 3′ end blocks including phosphotyrosine-DNA conjugates (Top1cc), 2′,3′-cyclic phosphates, and their hydrolysis products; APN2 deletion suppresses 2-bp slippage mutagenesis in RNH201-deficient cells, placing Apn2 as an additional nuclease that processes Top1-induced DNA ends independently of Tdp1.\",\n      \"method\": \"Yeast genetics (deletion mutants, epistasis), in vitro biochemical assays with defined DNA substrates bearing 3′ adducts\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro enzymatic activity on defined substrates combined with genetic epistasis\",\n      \"pmids\": [\"30778235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Large Top1cc-dependent deletions in yeast are produced by the nonhomologous end-joining (NHEJ) pathway and require removal of Top1 from DNA ends; these deletions accumulate in quiescent cells, suggesting that Top1-associated DSBs can arise outside of replication, with NHEJ joining ends from different Top1-associated DSBs to delete intervening sequence.\",\n      \"method\": \"Yeast genetics with NHEJ mutants, Top1cc stabilisation by top1-T722A allele and CPT, molecular characterisation of deletion junctions\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with junction-level molecular characterisation, single lab\",\n      \"pmids\": [\"31636207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In budding yeast, Top1 physically interacts with the fork protection complex component Tof1 through Tof1's C-terminal domain; this interaction is required for programmed replication fork pausing at the rDNA replication fork barrier (RFB), and Top2 can partially compensate for the absence of Top1 in this context.\",\n      \"method\": \"Physical interaction assays (Tof1-Top1 interaction), genetic analysis of tof1 mutants defective for Top1 binding, replication fork pausing assays at rDNA RFB\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — protein interaction + genetic analysis, commentary citing primary work by Shyian et al.\",\n      \"pmids\": [\"31896687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TDP1-independent repair of Top1cc in yeast involves the nucleotide excision repair pathway components Rad16-Swi10 as alternative Top1cc repair factors; Top1cc-induced DNA damage causes hyper-recombination and checkpoint-mediated cell cycle arrest when both Tdp1 and this NER pathway are absent.\",\n      \"method\": \"Yeast epistasis genetics, ChIP-qPCR quantification of Top1ccs, checkpoint analysis\",\n      \"journal\": \"NAR cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — review synthesising ChIP and genetic data from primary studies; mechanistic synthesis\",\n      \"pmids\": [\"33981998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Abraxas restricts SLX4/MUS81 recruitment to CPT-induced (TOP1cc-derived) single-ended DSBs by counteracting K63-linked ubiquitin modification; without Abraxas, uncontrolled SLX4/MUS81 loading leads to excessive MRE11-CtIP-DNA2/BLM-dependent end resection and increased break-induced replication (BIR) via RAD52- and POLD3-dependent, RAD51-independent synthesis, resulting in chromosome aberrations.\",\n      \"method\": \"Genetic knockouts (Abraxas, SLX4, MUS81, MRE11, CtIP, RAD52, POLD3, RAD51), camptothecin treatment, measurement of mitotic DNA synthesis, ubiquitin modification assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple isogenic knockouts with mechanistic pathway dissection and functional readouts\",\n      \"pmids\": [\"34272385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Crystal structure of the archaeal Caldiarchaeum subterraneum CsTOP1 in apo (DNA-free) open conformation revealed that the enzyme consists of capping (CAP) and catalytic (CAT) modules connected by a flexible five-residue hinge loop; a conserved tyrosine near the hinge mediates the transition from open to closed conformation upon DNA binding; directed mutagenesis of hinge residues confirmed the importance of hinge flexibility and linked enzyme dynamics to camptothecin sensitivity.\",\n      \"method\": \"X-ray crystallography of apo-form archaeal TOP1, directed mutagenesis of hinge residues, camptothecin sensitivity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure + mutagenesis + functional validation in one study\",\n      \"pmids\": [\"35013228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Whole-genome CRISPR screens in TDP1-knockout cells identified MUS81 as a key mediator of excess DSB formation when TDP1 is absent: TDP1 KO cells show synthetic lethality with APEX1/2 deficiency but not via reduced DSB formation, indicating that TOP1cc can be either directly resolved by TDP1 or converted to DSBs and repaired by the homologous recombination pathway.\",\n      \"method\": \"Unbiased whole-genome CRISPR screens, generation of TDP1/MUS81 and TDP1/APEX co-deficient cell lines, DSB quantification\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — unbiased CRISPR screen validated in isogenic co-deficient cells with mechanistic DSB readouts\",\n      \"pmids\": [\"35869071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TOP1-mediated mutagenesis at genome-embedded ribonucleotides generates a characteristic insertion-deletion mutational signature (ID4: 2–5 bp deletions at TNT motifs); defective ribonucleotide excision repair in mammals leads to accumulation of this TOP1-mediated signature both in cancer and in the germline, establishing that TOP1 activity at rNMP sites is a source of somatic and germline mutations.\",\n      \"method\": \"Mutational signature analysis in cancer genomes and germline de novo mutations, mouse models with defective ribonucleotide excision repair, identification of TNT sequence motif\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic link between TOP1 and rNMP-dependent mutagenesis established in mammalian models and human cancer/germline data\",\n      \"pmids\": [\"35140396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Exatecan forms two novel molecular contacts with the TOP1 cleavage complex beyond the three classical camptothecin interaction sites (R364, D533, N722): additional interactions with the flanking DNA base and TOP1 residue N352 result in stronger TOP1 trapping and higher DNA damage than classical camptothecin derivatives.\",\n      \"method\": \"Molecular modelling of exatecan in the TOP1 cleavage complex, comparison of TOP1 trapping and DNA damage with clinical TOP1 inhibitors, cell-based apoptosis and xenograft assays\",\n      \"journal\": \"Molecular cancer therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1/3 — structural modelling supported by cellular and in vivo pharmacological data, but no direct crystal structure of exatecan-TOP1cc\",\n      \"pmids\": [\"35439320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TOP1 CAD-seq protocol enables genome-wide mapping of TOP1 sites of covalent engagement (cleavage complexes) with DNA using chaotropic salt enrichment and immunoprecipitation with a TOP1-specific antibody, without crosslinking, providing low-background maps of catalytically active TOP1 across the human genome.\",\n      \"method\": \"Chaotropic salt-based enrichment of TOP1-DNA adducts, anti-TOP1 immunoprecipitation, Illumina sequencing\",\n      \"journal\": \"STAR protocols\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — methodological paper describing direct biochemical capture of TOP1cc genome-wide\",\n      \"pmids\": [\"35942340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Abortive TOP1 activity during gene transcription generates protein-linked SSBs (TOP1cc) that can lead to DSBs; these transcription-associated DSBs are a source of chromosomal translocations suppressed by TDP1; the translocations arise via an error-prone pathway requiring the MRN complex and canonical NHEJ, distinct from replication-associated TOP1 damage.\",\n      \"method\": \"Human cell TDP1 depletion, chromosomal translocation mapping, DSB mapping during transcription, MRN and NHEJ pathway genetic dissection\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic dissection of pathway with chromosomal-level mechanistic readouts, multiple independent validations\",\n      \"pmids\": [\"37945566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MUS81 can cleave DNA-protein cross-links (DPCs) derived from TOP1, but only after TOP1 has been dislodged or partially proteolytically degraded (native full-length TOP1 blocks MUS81 cleavage); depletion of TDP1 in MUS81-KO cells confers sensitivity to CPT and affects cell proliferation only partially rescued by TOP1 depletion, indicating that MUS81 and TDP1 act in independent pathways to remove TOP1-derived lesions.\",\n      \"method\": \"In vitro MUS81 cleavage assays on DPC substrates (fluorescein, streptavidin, proteolytically processed TOP1), nuclear extract cleavage assays, TDP1/MUS81 double-KO cell viability assays, CPT sensitivity\",\n      \"journal\": \"BMC biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution with defined substrates plus genetic knockouts with functional readouts\",\n      \"pmids\": [\"37194054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TOP1 and R-loops co-occupy highly transcribed cancer driver genes; depletion of R-loops (by RNase H overexpression) or depletion of TOP1 significantly reduces transcription-associated DSBs at these loci, demonstrating that TOP1 and R-loops cooperate to generate DSBs at hypertranscribed genes, contributing to early driver mutations in cancer.\",\n      \"method\": \"DSB mapping, R-loop mapping (DRIP-seq), TOP1cc mapping, TOP1 and RNase H depletion experiments in cancer cells\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple genomic mapping methods combined with TOP1 depletion and R-loop removal, single lab\",\n      \"pmids\": [\"38375218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CDK1 phosphorylates TDP1 at residue S61 during mitosis to promote repair of trapped Top1cc (Top1-DNA covalent complexes); a TDP1-S61A phospho-deficient variant is trapped on mitotic chromosomes and causes DNA damage and mitotic defects; Top1cc repair in mitosis occurs through a MUS81-dependent mechanism; replication stress leads to TDP1-S61A enrichment at common fragile sites, causing MUS81-dependent chromatid breaks, anaphase bridges and micronuclei.\",\n      \"method\": \"Identification of CDK1 phosphorylation site by mutagenesis, phospho-deficient TDP1-S61A cell lines, mitotic chromosome imaging, MUS81 epistasis, camptothecin/aphidicolin treatment\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — phosphorylation site identified and validated by mutagenesis, multiple cellular phenotypes, pathway placed via MUS81 epistasis\",\n      \"pmids\": [\"39014228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TOP1 resistance mutations (S57C, R364H, W401C, G359E) arising in metastatic breast cancer patients after ADC treatment show reduced enzymatic activity, attenuated covalent DNA binding, and resistance to TOP1 inhibitor payloads SN-38 and deruxtecan, establishing these as gain-of-function resistance alleles at structurally important positions.\",\n      \"method\": \"Plasma-based genotyping from patients progressing on ADC therapy, functional characterisation of recombinant TOP1 mutant proteins (enzymatic activity, covalent DNA binding, drug resistance assays)\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro biochemical characterisation of patient-derived mutant proteins with multiple functional assays\",\n      \"pmids\": [\"39745368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Human TOP1 residues 236 and 237 are required for interaction with BTBD2 (and BTBD1); replacement of these residues with the African Green Monkey counterparts abolishes both the infectivity enhancement of progeny HIV-1 virions and the TOP1-BTBD2 interaction, suggesting TOP1 modulates HIV-1 viral tropism through its interaction with BTBD2 in cytoplasmic bodies.\",\n      \"method\": \"Co-immunoprecipitation of TOP1 with BTBD1/BTBD2, site-directed mutagenesis of TOP1 residues 236–237, HIV-1 infectivity assays in AGM and human cells, RNAi knockdown of BTBD2\",\n      \"journal\": \"Virology journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP + mutagenesis + RNAi phenotype, single lab, moderate functional follow-up\",\n      \"pmids\": [\"21092135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The NORAD lncRNA assembles a topoisomerase complex (NARC1) containing TOP1, ALYREF, and the PRPF19-CDC5L complex through interaction with RBMX; depletion of NORAD or RBMX leads to chromosome segregation defects, reduced replication-fork velocity, and altered cell-cycle progression linked to TOP1 and PRPF19-CDC5L function; NORAD acts by modulating the ability of RBMX to assemble this ribonucleoprotein complex.\",\n      \"method\": \"RNA antisense purification combined with quantitative mass spectrometry, NORAD/RBMX depletion with phenotypic analysis (chromosome segregation, replication fork velocity, cell cycle), rescue experiments with RBMX-binding site deletion\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — biochemical purification identifying complex components validated by depletion and rescue with defined binding-site mutant, multiple functional readouts\",\n      \"pmids\": [\"30150775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The ERCC1-XPF endonuclease together with RPA can cleave 3′-phosphotyrosyl bond nick DNA lesions mimicking Top1cc in vitro; ERCC1-XPF and RPA co-localize at CPT damage sites in vivo; NER factors including ERCC1-XPF, RPA, DNA polymerase δ, FEN1, and DNA ligase 1 together support repair synthesis of Top1-attached nick DNA lesions, establishing an NER-related repair pathway for Top1cc.\",\n      \"method\": \"In vitro nuclease activity assays on phosphotyrosyl-nick DNA substrate, EMSA, co-localization by immunofluorescence in CPT-treated cells, in vitro DNA repair synthesis reconstitution\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of endonuclease activity and repair synthesis plus in vivo co-localization\",\n      \"pmids\": [\"26025908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In vertebrate (chicken DT40) cells, TOP1 and TOP2 have complementary roles in DNA replication: depletion of TOP1 alone or inhibition of TOP2 alone does not impair replication fork progression, but combining TOP1 depletion with TOP2 inhibition nearly abolishes DNA replication, causing S-phase arrest and apoptosis; additionally, TOP2 poison etoposide (but not the TOP2 inhibitor ICRF193) in TOP1-depleted cells causes G1/early S-phase arrest, implicating TOP1 in replication initiation.\",\n      \"method\": \"Conditional TOP1 knockout in DT40 cells, ICRF193 (TOP2 inhibitor) and etoposide (TOP2 poison) treatment, DNA replication rate measurement, cell-cycle analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional vertebrate knockout with pharmacological TOP2 inhibition, multiple complementary assays\",\n      \"pmids\": [\"41791707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Top1 activity promotes repressed chromatin at the rDNA locus in S. cerevisiae: deletion of TOP1 causes increased histone acetylation at the rDNA locus similar to sir2 deletion; in both top1 and sir2 mutants, rDNA chromatin becomes more accessible.\",\n      \"method\": \"Chromatin accessibility assays and histone acetylation analysis at rDNA locus in top1Δ and sir2Δ yeast strains\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — chromatin biochemistry in genetic mutants, single lab\",\n      \"pmids\": [\"12215413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The t(11;20)(p15;q11) chromosomal translocation in therapy-related MDS produces a chimeric NUP98-TOP1 mRNA in which the N-terminal FXFG repeat region of NUP98 is fused in-frame to the body of TOP1 (from exon 8 onwards), identifying TOP1 as a recurrent translocation target in haematological malignancies; the NUP98 FXFG domain is separated from its RNA-binding domain by the breakpoint.\",\n      \"method\": \"Molecular cloning of translocation breakpoint, RT-PCR, sequencing of chimeric transcript\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — cloning and characterisation of fusion gene, clinical samples, single study\",\n      \"pmids\": [\"10556215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TOPORS, a SUMO E3 ligase/ubiquitin ligase, promotes SUMO1 modification (SUMOylation) of TOP1 in macrophages; knockdown of TOPORS reduces SUMO1-TOP1 levels and increases TOP1 protein and γH2AX (DNA damage marker) in ovalbumin-stimulated macrophages, indicating that TOPORS-mediated SUMO1 modification of TOP1 facilitates DNA damage repair in oxidative stress conditions.\",\n      \"method\": \"Immunoprecipitation to detect SUMO1-TOP1 conjugates, TOPORS knockdown (RNAi), γH2AX immunofluorescence, OVA-stimulated macrophage model\",\n      \"journal\": \"Toxicology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP for modification + knockdown phenotype, single lab, limited mechanistic detail\",\n      \"pmids\": [\"40532862\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human TOP1 is a type IB topoisomerase that relieves DNA torsional stress by clamping around duplex DNA, nicking one strand via active-site Tyr-723, allowing controlled rotation of the downstream DNA, and religating the nick; camptothecin-class drugs intercalate at the cleavage site to trap the covalent TOP1-DNA cleavage complex (TOP1cc), which is repaired by TDP1 (direct hydrolysis of the phosphotyrosyl bond) or by redundant pathways including ERCC1-XPF/NER, MUS81 (after TOP1 proteolysis), and homologous recombination, with PARP1-mediated PARylation, CDK1-dependent TDP1 phosphorylation, and SUMO/ubiquitin modifications further regulating TOP1 dynamics and TOP1cc removal; TOP1 works cooperatively with TOP2 at replication forks and during transcription to prevent accumulation of supercoils and R-loops, and its abortive activity at ribonucleotides generates a distinctive deletion mutational signature contributing to cancer and germline instability.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TOP1 is a type IB DNA topoisomerase that relieves torsional stress during replication and transcription by transiently cleaving one DNA strand through a covalent 3'-phosphotyrosyl intermediate (Top1 cleavage complex, Top1cc), acting coordinately with TOP2 within ~600 bp of moving replication forks to prevent supercoil accumulation [PMID:2997777, PMID:17671091]. Abortive Top1cc intermediates—stabilized by camptothecin, genome-embedded ribonucleotides, or oxidative stress—are repaired through parallel pathways: TDP1-mediated hydrolysis of the phosphotyrosyl bond and structure-specific endonucleases (Rad1-Rad10/ERCC1-XPF and MUS81), with unrepaired Top1ccs generating replication- and transcription-associated double-strand breaks channeled into homologous recombination or NHEJ [PMID:12368472, PMID:35869071, PMID:26025908, PMID:37945566]. TOP1 cleavage at ribonucleotides embedded in DNA produces characteristic 2–5 bp deletions (ID4 mutational signature) via a sequential nick-realignment-ligation mechanism, linking TOP1 to genome mutagenesis when ribonucleotide excision repair is defective [PMID:35140396, PMID:27257064]. TOP1 subnuclear dynamics and Top1cc turnover are regulated by PARP1-mediated PARylation and SUMO/ubiquitin modifications that control nucleolar retention and proteasomal degradation [PMID:27466387, PMID:21408210].\",\n  \"teleology\": [\n    {\n      \"year\": 1985,\n      \"claim\": \"Establishing that TOP1 encodes the sole topoisomerase I in yeast and is auxiliary to TOP2 for viability resolved the genetic identity of type IB topoisomerase activity and revealed functional redundancy between TOP1 and TOP2.\",\n      \"evidence\": \"Gene cloning, insertion-deletion mutagenesis, and extract activity assays in S. cerevisiae\",\n      \"pmids\": [\"2997777\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of DNA relaxation by Top1 not yet defined at atomic level\", \"No mammalian TOP1 knockout phenotype established\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrating that Top1 is required for nucleosome assembly-coupled DNA supercoiling extended its role beyond simple torsional relief to chromatin dynamics.\",\n      \"evidence\": \"In vitro nucleosome assembly assay with top1-deficient Ustilago maydis extracts complemented by purified Top1\",\n      \"pmids\": [\"7476870\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single organism (Ustilago); not confirmed in yeast or mammalian systems\", \"Mechanism of Top1 participation in nucleosome assembly not delineated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of TDP1 and Rad1-Rad10 as parallel Top1cc repair pathways, both feeding into Rad52-dependent recombination, established the first framework for how cells resolve abortive Top1 cleavage complexes.\",\n      \"evidence\": \"Genetic epistasis with double/triple mutants and camptothecin sensitivity in S. cerevisiae\",\n      \"pmids\": [\"12368472\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian ortholog pathway (ERCC1-XPF) not yet validated biochemically\", \"Whether additional nucleases contribute was unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that Top1 catalytic activity regulates histone acetylation at rDNA and telomeric chromatin connected topoisomerase function to epigenetic regulation.\",\n      \"evidence\": \"ChIP for histone modifications in TOP1 deletion and catalytic-dead Y727F mutant yeast strains\",\n      \"pmids\": [\"18272174\", \"12215413\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking Top1 catalysis to histone modification enzymes not identified\", \"Causality versus correlation at rDNA not fully resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genome-wide mapping of Top1 and Top2 at replication forks showed they act coordinately within ~600 bp of fork junctions; only combined loss triggers checkpoint activation, resolving why single top1 mutants have mild phenotypes.\",\n      \"evidence\": \"ChIP-on-chip, 2D gel electrophoresis, and checkpoint assays in S. cerevisiae\",\n      \"pmids\": [\"17671091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether similar co-distribution applies to mammalian replication forks not shown\", \"Mechanism of Top1/Top2 recruitment to forks uncharacterized\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"SUMO-targeted ubiquitin ligase (STUbL) and SUMO E3 ligase Nse2 were shown to suppress spontaneous Top1cc accumulation, linking the SUMO/ubiquitin cascade to Top1cc turnover and revealing a proteasome-dependent clearance mechanism.\",\n      \"evidence\": \"ChIP-qPCR for Top1cc levels and genetic epistasis with Tdp1 and endonuclease mutants in S. pombe\",\n      \"pmids\": [\"21408210\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ubiquitination of Top1 not biochemically reconstituted in this study\", \"Mammalian STUbL pathway for Top1cc not confirmed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that reversible Top1ccs are specifically stabilized at the rDNA replication fork barrier in a Fob1/Tof2-dependent manner revealed a physiological, non-pathological role for Top1cc formation in rDNA stability.\",\n      \"evidence\": \"ChIP-qPCR for Top1cc at native and ectopic rRFBs, genetic analysis in S. cerevisiae\",\n      \"pmids\": [\"24574527\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Fob1/Tof2 recruit or stabilize Top1 mechanistically is unknown\", \"Whether similar mechanism operates at mammalian rDNA barriers not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Biochemical reconstitution showed ERCC1-XPF endonuclease cleaves Top1-linked nick DNA substrates with RPA, establishing the mammalian ortholog of the yeast Rad1-Rad10 Top1cc repair pathway.\",\n      \"evidence\": \"In vitro nuclease assay on defined tyrosyl-nick substrates, co-localization at CPT damage sites, cell-free repair synthesis\",\n      \"pmids\": [\"26025908\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of ERCC1-XPF pathway relative to TDP1 in vivo not quantified\", \"Structural basis for ERCC1-XPF recognition of Top1cc lesion unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that stabilized Top1cc causes elevated reciprocal crossovers and instability specifically at tandem repeats (rDNA, CUP1) but not single-copy loci clarified the genomic context of Top1cc-mediated genome instability.\",\n      \"evidence\": \"LOH sectoring assay, microarray-based crossover mapping, long-term subculturing in S. cerevisiae\",\n      \"pmids\": [\"25830313\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether repeat instability is replication- or transcription-associated not fully resolved\", \"Mammalian tandem repeat instability from Top1cc not directly tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Reconstitution of Top1-mediated deletion mutagenesis at ribonucleotides revealed a sequential cleavage-realignment-ligation mechanism, explaining how Top1 generates 2–5 bp deletions at tandem repeats containing rNMPs.\",\n      \"evidence\": \"In vitro biochemical reconstitution with purified Top1 on defined rNMP substrates and in vivo yeast genetic assays\",\n      \"pmids\": [\"27257064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian TOP1 uses identical mechanism not directly reconstituted\", \"Rate-limiting step in the sequential reaction not determined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"PARP1-dependent PARylation was shown to control Top1 nucleolar-nucleoplasmic shuttling and Top1cc immobilization, establishing post-translational regulation of Top1 subnuclear dynamics.\",\n      \"evidence\": \"FRAP kinetics of GFP-Top1 with PARP inhibitors, site-directed mutagenesis of W205 and N722 in human cells\",\n      \"pmids\": [\"27466387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which PARylation sites on Top1 mediate shuttling not mapped\", \"Functional consequence of altered dynamics for DNA repair not quantified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of Top1cc-dependent large deletions (~100 bp) produced by NHEJ in quiescent cells demonstrated that Top1cc can cause genome instability outside of replication through transcription-associated DSBs.\",\n      \"evidence\": \"Junction analysis of deletions, NHEJ mutant epistasis, and top1-T722A in quiescent S. cerevisiae\",\n      \"pmids\": [\"31636207\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Source of DSBs in quiescent cells (transcription vs. spontaneous) not fully delineated\", \"Whether same mechanism generates deletions in mammalian non-dividing cells unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that the AP endonuclease Apn2 resolves 3'-phosphotyrosine conjugates, cyclic phosphates, and hydrolysis products at Top1-rNMP sites added a third enzymatic pathway for Top1cc resolution beyond TDP1 and endonucleases.\",\n      \"evidence\": \"In vitro biochemistry with purified Apn2 on defined Top1cc substrates and genetic validation in RNH201-deficient yeast\",\n      \"pmids\": [\"30778235\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian APE2 activity on Top1cc substrates not tested\", \"Relative contribution of Apn2 versus TDP1 in vivo not quantified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Physical interaction of the Tof1-Csm3 fork protection complex with Top1 through Tof1's C-terminal domain connected Top1 to programmed fork pausing at the rDNA barrier.\",\n      \"evidence\": \"Co-IP/two-hybrid for Tof1-Top1 interaction, genetic analysis of rDNA RFB pausing\",\n      \"pmids\": [\"31896687\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of Tof1-Top1 interaction unknown\", \"Whether Tof1 regulates Top1 catalysis or merely recruits it not determined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Genome-wide CRISPR screens and biochemistry established MUS81 as the key nuclease generating DSBs from trapped Top1cc in TDP1-deficient cells, with MUS81 requiring prior Top1 dislodgment or proteolysis before cleavage, clarifying the substrate requirements of the endonuclease pathway.\",\n      \"evidence\": \"CRISPR screens, co-deficient cell lines, DSB assays, in vitro MUS81 cleavage on processed Top1cc substrates\",\n      \"pmids\": [\"35869071\", \"37194054\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protease(s) responsible for Top1 dislodgment in vivo not identified\", \"How cells choose between TDP1 and MUS81 pathways not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mutational signature analysis in RER-deficient mammalian cells attributed the ID4 signature (2–5 bp deletions at TNT motifs) to TOP1 cleavage at genomic ribonucleotides, linking Top1 mutagenesis to cancer genomes.\",\n      \"evidence\": \"Genome sequencing of RER-deficient cells with TOP1 depletion, mutational signature decomposition\",\n      \"pmids\": [\"35140396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ID4 mutations are transcription- or replication-coupled in vivo not resolved\", \"Contribution of individual rNMP sites versus rNMP clusters unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Crystal structure of archaeal CsTOP1 in the apo open conformation revealed a CAP-CAT hinge-mediated open-to-closed transition upon DNA binding, providing the first structural basis for the DNA clamp mechanism of type IB topoisomerases.\",\n      \"evidence\": \"X-ray crystallography of apo CsTOP1, mutagenesis of hinge residues, camptothecin sensitivity\",\n      \"pmids\": [\"35013228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No eukaryotic TOP1 apo structure available for direct comparison\", \"Dynamics of the hinge during catalysis not captured\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstration that abortive TOP1 activity causes transcription-associated DSBs that generate chromosomal translocations via MRN/NHEJ, suppressed by TDP1, established Top1cc as a direct source of structural variants in mammalian genomes.\",\n      \"evidence\": \"DSB and TOP1cc co-mapping, TDP1-KO translocation assays, NHEJ/MRN genetic epistasis\",\n      \"pmids\": [\"37945566\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Frequency of TOP1cc-driven translocations in normal tissues unknown\", \"Whether specific genomic loci are hotspots for TOP1cc-driven translocations not systematically mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"CDK1-mediated phosphorylation of TDP1-S61 during mitosis evicts TDP1 from chromosomes, revealing that Top1cc repair pathway choice is cell-cycle regulated—MUS81 becomes the dominant pathway in mitosis, and TDP1 retention causes fragile site breakage.\",\n      \"evidence\": \"CDK1 kinase assay, mass spectrometry, phospho-deficient TDP1-S61A mutant phenotyping, MUS81 epistasis\",\n      \"pmids\": [\"39014228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other CDK substrates coordinate Top1cc repair pathway switching not examined\", \"Mitotic Top1cc levels and dynamics not directly measured\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural mechanism of the human TOP1 open-to-closed DNA clamping transition, how cells choose between TDP1, MUS81, and Apn2/APE2 repair pathways in different cell-cycle phases and genomic contexts, and whether Top1cc-mediated mutagenesis and translocations contribute quantitatively to cancer initiation or progression in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No human apo TOP1 structure available\", \"Pathway choice determinants between TDP1, MUS81, and APE2 not defined\", \"In vivo cancer-relevant contribution of Top1cc mutagenesis not quantified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 2, 4, 8, 12]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 6, 18]},\n      {\"term_id\": \"GO:0016853\", \"supporting_discovery_ids\": [0, 6, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [2, 12, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [1, 5, 7, 11, 13, 14]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [2, 12, 23]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [18, 19, 24]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"TDP1\",\n      \"MUS81\",\n      \"PARP1\",\n      \"ERCC1\",\n      \"XPF\",\n      \"TOF1\",\n      \"TOPORS\",\n      \"BTBD2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"TOP1 is a type IB DNA topoisomerase that relieves torsional stress generated during replication and transcription by clamping around duplex DNA, cleaving one strand via the active-site nucleophile Tyr-723 to form a covalent 3′-phosphotyrosyl intermediate (TOP1 cleavage complex, TOP1cc), allowing controlled rotation of the downstream duplex, and religating the nick [PMID:9488644, PMID:9488652]. TOP1 acts cooperatively with TOP2 within ~600 bp of replication forks and at replication initiation; loss of both topoisomerases arrests fork progression and activates the DNA damage checkpoint [PMID:17671091, PMID:41791707]. Camptothecin-class drugs trap the TOP1cc by intercalating at the cleavage site, and trapped complexes are resolved by redundant pathways including TDP1-mediated phosphotyrosyl hydrolysis, ERCC1-XPF/NER endonuclease cleavage, and MUS81-dependent processing after TOP1 proteolysis, with PARP1-dependent PARylation and SUMO/ubiquitin modifications further regulating TOP1cc dynamics and repair [PMID:12426403, PMID:12368472, PMID:26025908, PMID:37194054, PMID:27466387]. Abortive TOP1 activity at genome-embedded ribonucleotides generates a characteristic 2–5 bp deletion mutational signature (ID4) contributing to both somatic and germline mutagenesis, and transcription-coupled TOP1cc formation at hypertranscribed loci cooperates with R-loops to produce DSBs and chromosomal translocations [PMID:35140396, PMID:37945566, PMID:38375218].\",\n  \"teleology\": [\n    {\n      \"year\": 1985,\n      \"claim\": \"Establishing that TOP1 is dispensable for viability as a single mutant but essential in the absence of TOP2 defined the cooperative, partially redundant relationship between the two topoisomerases in chromosome metabolism.\",\n      \"evidence\": \"Yeast TOP1 deletion and top1Δ top2-ts double-mutant viability assays\",\n      \"pmids\": [\"2997777\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic basis of TOP1–TOP2 functional overlap at specific genomic loci was unknown\", \"Whether TOP1 deletion affects replication fork dynamics was not addressed\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Cloning of human TOP1 and mapping the catalytic activity to the C-terminal 67.7-kDa fragment containing Tyr-723 established the domain architecture and active-site residue of the human enzyme.\",\n      \"evidence\": \"cDNA cloning, in vitro DNA relaxation assay, proteolysis mapping\",\n      \"pmids\": [\"2833744\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No three-dimensional structure available\", \"Mechanism of strand rotation after cleavage was unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Crystal structures of human TOP1 covalently and noncovalently bound to DNA revealed the clamp architecture, confirmed Tyr-723 as the active-site nucleophile, and led to the controlled-rotation model for DNA relaxation.\",\n      \"evidence\": \"X-ray crystallography at 2.1–2.8 Å of TOP1–DNA complexes\",\n      \"pmids\": [\"9488644\", \"9488652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Camptothecin binding site was inferred but not directly visualized\", \"Open-to-closed conformational transition mechanism was not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of TDP1 and Rad1-Rad10 (ERCC1-XPF) as two redundant primary pathways for TOP1cc repair, both requiring downstream homologous recombination, established the framework for understanding TOP1cc-associated DNA damage responses.\",\n      \"evidence\": \"Yeast genetic epistasis with tdp1 rad1 double mutants, camptothecin sensitivity assays\",\n      \"pmids\": [\"12368472\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional nucleases contribute to TOP1cc removal was unknown\", \"The role of proteasomal degradation of TOP1 before nucleolytic processing was not defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"The ternary crystal structure of TOP1–DNA–Topotecan directly showed that the camptothecin pharmacophore intercalates at the cleavage site to block religation, establishing the structural basis for uncompetitive TOP1 inhibition.\",\n      \"evidence\": \"X-ray crystallography of TOP1–DNA–Topotecan ternary complex\",\n      \"pmids\": [\"12426403\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for newer inhibitors (e.g., exatecan) awaited direct crystallographic confirmation\", \"How drug binding affects controlled rotation dynamics was not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genome-wide ChIP mapping showed TOP1 and TOP2 co-occupy a ~600 bp zone at replication forks; their combined loss but not single loss causes fork arrest and checkpoint activation, quantifying the redundancy at replication forks.\",\n      \"evidence\": \"ChIP genome-wide mapping of Top1/Top2 at replicating chromosomes in budding yeast, checkpoint kinase assays\",\n      \"pmids\": [\"17671091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TOP1 contributes specifically to replication initiation was not addressed\", \"Vertebrate confirmation of fork-proximal co-occupancy was lacking\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery that TOP1 catalytic activity promotes a repressed chromatin state at telomere-proximal regions and rDNA broadened TOP1 function beyond supercoil relaxation to include chromatin organization.\",\n      \"evidence\": \"Microarray expression profiling, ChIP, and catalytic-dead Y727F mutant analysis in yeast\",\n      \"pmids\": [\"18272174\", \"12215413\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct mechanism linking TOP1 catalysis to histone deacetylation was not identified\", \"Whether this chromatin role is conserved in mammals was not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Biochemical reconstitution of ERCC1-XPF/RPA-mediated cleavage and repair synthesis on phosphotyrosyl-nick substrates established a complete NER-related repair pathway for TOP1cc in mammalian cells.\",\n      \"evidence\": \"In vitro nuclease assays on phosphotyrosyl-nick DNA, repair synthesis reconstitution, co-localization by immunofluorescence in CPT-treated cells\",\n      \"pmids\": [\"26025908\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of NER versus TDP1 in different cell types was not quantified\", \"Whether this pathway operates during transcription-associated TOP1cc was not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstration that TOP1 performs ribonucleotide-dependent deletions via a sequential double-cleavage mechanism at tandem repeats defined the enzymatic basis of TOP1-mediated mutagenesis.\",\n      \"evidence\": \"In vitro TOP1 cleavage assays on defined substrates paralleled by in vivo yeast mutation assays\",\n      \"pmids\": [\"27257064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide prevalence of this mechanism in mammalian cells was not yet established\", \"Whether deletion size is influenced by chromatin context was unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"PARP1-mediated PARylation was shown to regulate TOP1 subnuclear dynamics, with PARP inhibition delocalizing TOP1 from the nucleolus and increasing genome-wide TOP1cc trapping, linking PARP activity to TOP1 function.\",\n      \"evidence\": \"Live-cell FRAP imaging, PARP inhibitor treatment, TOP1 mutagenesis (W205, N722S)\",\n      \"pmids\": [\"27466387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific TOP1 residue(s) are PARylated was not identified\", \"Whether PARP inhibitor–TOP1 synergy is clinically exploitable beyond camptothecin was not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of the NORAD lncRNA–RBMX–TOP1–PRPF19-CDC5L complex (NARC1) revealed that TOP1 participates in a ribonucleoprotein complex required for genome stability and normal replication fork progression.\",\n      \"evidence\": \"RNA antisense purification with quantitative mass spectrometry, NORAD/RBMX depletion phenotypic analysis, rescue with binding-site mutant\",\n      \"pmids\": [\"30150775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical role of TOP1 within NARC1 was not dissected\", \"Whether NARC1 function requires TOP1 catalytic activity was not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of Apn2 as an additional nuclease resolving TOP1-derived 3′ adducts expanded the repertoire of TOP1cc repair enzymes beyond TDP1 and NER.\",\n      \"evidence\": \"In vitro biochemistry on defined 3′-adduct substrates and yeast epistasis with APN2, TDP1, RNH201 deletions\",\n      \"pmids\": [\"30778235\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian APE1/APE2 perform analogous TOP1cc resolution was not demonstrated\", \"Relative flux through Apn2 versus TDP1 pathways in vivo was not quantified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Abraxas was shown to restrict SLX4/MUS81 recruitment to TOP1cc-derived single-ended DSBs, preventing excessive end resection and aberrant break-induced replication; this placed ubiquitin-dependent regulation at the center of TOP1cc-to-DSB processing.\",\n      \"evidence\": \"Isogenic knockouts of Abraxas, SLX4, MUS81, MRE11, CtIP, RAD52, POLD3 with CPT treatment and mitotic DNA synthesis readouts\",\n      \"pmids\": [\"34272385\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which E3 ligase deposits the K63-ubiquitin chains counteracted by Abraxas was not identified\", \"In vivo contribution to camptothecin drug response was not assessed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mutational signature analysis in cancer genomes and mouse models established that TOP1 activity at genome-embedded ribonucleotides generates the characteristic ID4 deletion signature in both somatic and germline contexts, directly linking TOP1 catalysis to mutagenesis.\",\n      \"evidence\": \"Mutational signature analysis in cancer and germline data, mouse models with defective RER, TNT motif identification\",\n      \"pmids\": [\"35140396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TOP1-mediated mutagenesis rates vary across tissues or cell types was not resolved\", \"Potential protective role of accessory helicases was not examined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Genome-wide CRISPR screens in TDP1-KO cells confirmed MUS81 as the key nuclease generating DSBs from unresolved TOP1cc, and revealed synthetic lethality between TDP1 and APEX1/2, refining the network of TOP1cc repair pathways.\",\n      \"evidence\": \"Unbiased CRISPR screen, isogenic TDP1/MUS81 and TDP1/APEX co-deficient cell lines, DSB quantification\",\n      \"pmids\": [\"35869071\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether APEX1/2 directly process TOP1cc or act indirectly was not determined\", \"Pathway hierarchy under physiological versus drug-induced TOP1cc loads was not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstration that transcription-associated TOP1cc generate DSBs and chromosomal translocations suppressed by TDP1 via an MRN/NHEJ-dependent pathway distinguished transcription-coupled TOP1 damage from replication-coupled damage.\",\n      \"evidence\": \"TDP1 depletion in human cells, translocation mapping, MRN and NHEJ genetic dissection\",\n      \"pmids\": [\"37945566\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether specific gene loci are predisposed to transcription-coupled TOP1 translocations was not systematically mapped\", \"Contribution to therapy-related secondary malignancies was not directly tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"CDK1-mediated phosphorylation of TDP1 at S61 was shown to be required for efficient mitotic TOP1cc repair; failure of this regulation causes MUS81-dependent fragile-site breaks and chromosome missegregation, establishing cell-cycle-dependent regulation of TOP1cc resolution.\",\n      \"evidence\": \"TDP1-S61A phospho-deficient mutant cell lines, mitotic chromosome imaging, MUS81 epistasis, CPT/aphidicolin treatment\",\n      \"pmids\": [\"39014228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional CDK substrates in the TOP1cc repair network exist was not addressed\", \"Mitotic TOP1cc repair was not evaluated in the context of therapeutic TOP1 inhibitors\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Functional characterization of clinical TOP1 resistance mutations (S57C, R364H, W401C, G359E) arising under ADC therapy showed reduced catalytic activity and attenuated covalent DNA binding, defining mechanisms of acquired resistance to TOP1 inhibitor payloads.\",\n      \"evidence\": \"Recombinant mutant TOP1 proteins assayed for enzymatic activity, covalent DNA binding, and drug resistance; patient plasma genotyping\",\n      \"pmids\": [\"39745368\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether combination strategies can overcome these resistance alleles was not tested\", \"Structural basis for resistance at each site lacks direct crystallographic data\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: how TOP1 catalytic activity within the NARC1 RNP complex contributes to genome stability; the structural basis of the open-to-closed conformational transition in human TOP1; the relative pathway flux through TDP1, NER, and MUS81 routes under physiological versus drug-induced TOP1cc loads; and whether TOP1-mediated mutagenesis rates are tissue-specific.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No reconstitution of NARC1-dependent TOP1 function\", \"No human TOP1 apo-form crystal structure\", \"No quantitative in vivo measurement of pathway choice for TOP1cc repair\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 2, 3, 11]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 3, 4]},\n      {\"term_id\": \"GO:0016853\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [6, 7, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [6, 14, 28, 30]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [5, 8, 15, 16, 18, 23, 25, 29]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 22, 24]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7, 31]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [19, 26, 32]}\n    ],\n    \"complexes\": [\n      \"NARC1 (NORAD-RBMX-TOP1-PRPF19-CDC5L)\"\n    ],\n    \"partners\": [\n      \"TDP1\",\n      \"PARP1\",\n      \"MUS81\",\n      \"ERCC1\",\n      \"XPF\",\n      \"RBMX\",\n      \"TOF1\",\n      \"TOPORS\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}